



Insider trading history of Deerfield International Master Fund, L.p.    at Ehealth, Inc. 



















Insider Monitor



Realtime

Insider Buys 

Insider buys today     
Insider buys 1 day ago
Insider buys 2 days ago
Insider buys 3 days ago
Insider buys 4 days ago
Insider buys 5 days ago
Insider buys 6 days ago
Insider buys 7 days ago
Insider buys 8 days ago
Insider buys 9 days ago
Insider buys 10 days ago



Insider Sales 

Insider sales today       
Insider sales 1 day ago
Insider sales 2 days ago
Insider sales 3 days ago
Insider sales 4 days ago
Insider sales 5 days ago
Insider sales 6 days ago
Insider sales 7 days ago



Top 10 

Top 10 insider buys of the week
Top 10 officer buys of the week
Top 10 insider buys of the month
Top 10 officer buys of the month
Top 10 insider sales of the week
Top 10 insider sales of the month









               
		







 Insider Stock Trading History of Deerfield International Master Fund, L.p.  








The following table details the trading activities 
(stock purchases, stock sales, and stock option exercises) 
reported to 
the Securities and Exchange Commission (SEC) 
by insider Deerfield International Master Fund, L.p.  since year 2005. 
The trader's CIK number is 1565089.
At the time of this reporting, Deerfield International Master Fund, L.p.  is the  of Ehealth, Inc. . 
(stock ticker symbol EHTH).
See this page for all insider trading activities at Ehealth, Inc. . 


Note that in the past Deerfield International Master Fund, L.P. also reported insider trading activities as an insider of the following companies:
 Insider Activities at Ehealth, Inc.  (EHTH)
 Insider Activities at Zafgen, Inc.  (ZFGN)
 Insider Activities at Antares Pharma Inc  (AIS)
 Insider Activities at Loxo Oncology, Inc.  (LOXO)
 Insider Activities at Avalanche Biotechnologies, Inc.  (AAVL)




Stock purchases, sales, and option exercises reported by insider Deerfield International Master Fund, L.p.  since 2005.
  

   Trade Date   
 Symbol 
 Company Name (Issuer) 
 Trade Type 
     Shares   
     Price ($)
   Value ($) 

 2017-04-26  EHTH  Ehealth, Inc.   Sale  113,245  11.52  1,304,582 
 2017-04-27  EHTH  Ehealth, Inc.   Sale  313,709  11.71  3,673,532 
 2017-04-13  EHTH  Ehealth, Inc.   Sale  150,000  11.00  1,650,000 
 2017-04-07  EHTH  Ehealth, Inc.   Sale  118,904  11.72  1,393,079 
 2017-04-10  EHTH  Ehealth, Inc.   Sale  79,757  11.04  880,357 
 2017-04-11  EHTH  Ehealth, Inc.   Sale  33,440  11.01  368,241 
 2016-06-21  EHTH  Ehealth, Inc.   Sale  26,400  14.30  377,546 
 2016-06-20  EHTH  Ehealth, Inc.   Sale  178,454  14.20  2,533,511 
 2016-06-14  EHTH  Ehealth, Inc.   Sale  43,300  13.88  601,177 
 2016-06-06  EHTH  Ehealth, Inc.   Sale  28,502  14.00  399,028 
 2016-06-07  EHTH  Ehealth, Inc.   Sale  7,154  13.89  99,383 
 2016-06-08  EHTH  Ehealth, Inc.   Sale  28,080  13.84  388,627 
 2016-05-31  EHTH  Ehealth, Inc.   Sale  56,835  13.84  786,653 
 2016-06-02  EHTH  Ehealth, Inc.   Sale  42,668  13.87  591,762 
 2016-06-01  EHTH  Ehealth, Inc.   Sale  5  13.80  69 
 2016-05-25  EHTH  Ehealth, Inc.   Sale  45,967  14.25  655,167 
 2016-05-26  EHTH  Ehealth, Inc.   Sale  93,965  14.16  1,330,826 
 2016-05-27  EHTH  Ehealth, Inc.   Sale  72,649  14.00  1,016,940 
 2016-02-11  ZFGN  Zafgen, Inc.   Buy  2,344  6.19  14,504 
 2016-02-10  ZFGN  Zafgen, Inc.   Buy  151,226  6.23  942,440 
 2016-02-09  ZFGN  Zafgen, Inc.   Buy  113,923  5.73  652,664 
 2015-07-17  ATRS  Antares Pharma Inc   Sale  125,769  2.20  277,069 
 2015-07-20  ATRS  Antares Pharma Inc   Sale  106,024  2.13  225,407 
 2015-07-06  ATRS  Antares Pharma Inc   Sale  191,513  2.12  406,007 
 2015-07-07  ATRS  Antares Pharma Inc   Sale  198,651  2.09  414,783 
 2015-07-08  ATRS  Antares Pharma Inc   Sale  444,341  2.05  912,232 
 2015-07-01  ATRS  Antares Pharma Inc   Sale  43,836  2.11  92,318 
 2015-06-29  ATRS  Antares Pharma Inc   Sale  60,695  2.18  132,072 
 2015-06-30  ATRS  Antares Pharma Inc   Sale  608,691  2.08  1,266,685 
 2015-06-24  ATRS  Antares Pharma Inc   Sale  263,118  2.31  607,539 
 2015-06-25  ATRS  Antares Pharma Inc   Sale  175,200  2.25  394,200 
 2015-06-26  ATRS  Antares Pharma Inc   Sale  318,534  2.24  714,790 
 2015-06-19  ATRS  Antares Pharma Inc   Sale  141,550  2.41  340,569 
 2015-06-22  ATRS  Antares Pharma Inc   Sale  176,483  2.41  424,618 
 2015-06-23  ATRS  Antares Pharma Inc   Sale  181,862  2.35  427,193 
 2015-06-18  ATRS  Antares Pharma Inc   Sale  210,701  2.48  522,117 
 2015-06-17  ATRS  Antares Pharma Inc   Sale  53,605  2.40  128,920 
 2015-06-16  ATRS  Antares Pharma Inc   Sale  214,060  2.40  514,386 
 2015-06-15  ATRS  Antares Pharma Inc   Sale  190,141  2.40  456,718 
 2015-06-11  ATRS  Antares Pharma Inc   Sale  339,272  2.47  839,019 
 2015-06-12  ATRS  Antares Pharma Inc   Sale  218,617  2.43  530,364 
 2015-03-06  EHTH  Ehealth, Inc.   Sale  1,342,573  9.52  12,781,294 
 2014-08-07  EHTH  Ehealth, Inc.   Buy  3,131  21.05  65,907 
 2014-08-06  LOXO  Loxo Oncology, Inc.   Buy  1,089,656  13.02  14,184,052 
 2014-08-04  EHTH  Ehealth, Inc.   Buy  155,470  20.57  3,198,795 
 2014-08-05  EHTH  Ehealth, Inc.   Buy  3,770  20.99  79,132 
 2014-08-01  EHTH  Ehealth, Inc.   Buy  170,300  19.22  3,273,166 
 2014-08-05  AAVL  Avalanche Biotechnologies, Inc.   Buy  1,334,467  23.83  31,803,017 


Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more  information regarding the trades made by Deerfield International Master Fund, L.p.  
( of Ehealth, Inc.  at the time of this reporting) see 

the Securities and Exchange Commission (SEC)  website.


















 



















Newest Insider Buys 
Insider Trading Resources 
Archive  
Privacy  
Contact  
2016,2017 Market Holidays 
Market Hours 






Tweet



 ©2017, insider-monitor.com. All rights reserved. 
 

















Deerfield International Master Fund, L.P.


















graypools
Sign in
Learn more







Deerfield International Master Fund, L.P.
Hedge Fund






Institutional Investors

Hedge Funds

Deerfield International Master Fund, L.P.





















Deerfield International Master Fund, L.P.
is  a British Virgin Islands Hedge Fund located in New York,
New York.  
 






C/O Deerfield Management Company, L.P.
New York,
New York, 
10017 
United States
Phone: (212) 551-1600




Minimum Investment1.00M
JurisdictionBritish Virgin Islands
Updated2017-06-20 14:18:28.780854
NameDeerfield International Master Fund, L.P.
Latest Filing2017-05-31
As of Date2016-12-30
Private Fund ID805-6249376961
Legal Entity TypeLimited Partnership
Legal Entity Identifier5493006OA7301YZXYY65











Statements



Portfolio


Beneficial Owners












05-17




Portfolios
2.13B











05-17




Beneficial Owners
43.00

































About /
Entities /
Legal
© 2017 Graypools LLC










DEERFIELD INTERNATIONAL MASTER FUND, L.P. Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      DEERFIELD INTERNATIONAL MASTER FUND, L.P.
                    

•   NEW YORK, NY
                      
How do I update this listing?




                                             Deerfield International Master Fund is based out of New York.   
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from DEERFIELD INTERNATIONAL MASTER FUND, L.P., enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




deerfield international master fund, l.p.


780 THIRD AVENUE, 37TH FLOOR

NEW YORK
NY
                                                        
                                                    10017


                                                      Business Phone:
                                                      212-692-7108







Recent SEC Filings




4 filed on 06/14/2017
4 filed on 06/09/2017
4 filed on 04/27/2017
4 filed on 04/17/2017
4 filed on 04/11/2017
3 filed on 12/16/2016
4 filed on 09/26/2016
4 filed on 09/19/2016
4 filed on 08/01/2016
4 filed on 06/22/2016
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free




















Insider Trading - Deerfield International Master Fund L.P. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Deerfield International Master Fund L.P.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-09-22Sale
2016-09-265:29 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners L.P.Deerfield Special Situations Fund L.P.Other10% Owner
1,120,461
$16.56
$18,559,971
2,383,955(Indirect)
View


2016-09-15Sale
2016-09-196:42 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners L.P.Deerfield Special Situations Fund L.P.Other10% Owner
547,886
$15.66
$8,582,621
2,660,207(Indirect)
View


2016-07-20Sale
2016-08-017:14 pm
Zafgen Inc
ZFGN
Flynn James EDeerfield Mgmt L.P.Deerfield Partners L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Special Situations Fund L.P.Other10% Owner
1,341,499
$3.312
$4,442,776
1,151,802(Indirect)
View


2016-06-20Sale
2016-06-224:32 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
204,854
$14.21
$2,911,063
1,062,874(Indirect)
View


2016-06-14Sale
2016-06-165:37 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
43,300
$13.88
$601,169
1,062,874(Indirect)
View


2016-06-06Sale
2016-06-085:17 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
63,736
$13.92
$887,049
1,062,874(Indirect)
View


2016-05-31Sale
2016-06-025:17 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
99,508
$13.85
$1,378,435
1,073,157(Indirect)
View


2016-05-25Sale
2016-05-275:18 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
212,581
$14.13
$3,002,906
1,296,606(Indirect)
View


2016-02-19Purchase
2016-02-234:37 pm
Xenoport Inc
XNPT
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
20,973
$3.988
$83,647
6,667,391(Indirect)
View


2015-09-03Purchase
2016-02-1912:38 pm
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
750,317
$19.47
$14,605,330
1,623,089(Indirect)
View


2016-02-12Purchase
2016-02-172:02 pm
Zafgen Inc
ZFGN
Flynn James EDeerfield Mgmt L.P.Deerfield Partners LpDeerfield Management CoDeerfield International Master Fund L.P.Deerfield Special Situations Fund L.P.Other10% Owner
64,545
$6.247
$403,187
2,053,232(Indirect)
View


2016-02-11Purchase
2016-02-167:43 pm
Xenoport Inc
XNPT
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
4,883,761
$3.874
$18,917,621
6,667,391(Indirect)
View


2016-02-09Purchase
2016-02-118:21 pm
Zafgen Inc
ZFGN
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
267,493
$6.018
$1,609,668
2,039,360(Indirect)
View


2015-12-16Purchase
2015-12-187:43 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners LpDeerfield Special Situations Fund L.P.Other10% Owner
11,170
$8.967
$100,156
2,740,122(Indirect)
View


2015-12-09Purchase(A)
2015-12-187:40 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners LpDeerfield Special Situations Fund L.P.Other10% Owner
425,982
$8.604
$3,665,308
2,735,681(Indirect)
View


2015-12-09Purchase
2015-12-116:06 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners LpDeerfield Special Situations Fund L.P.Other10% Owner
1,201,364
$8.377
$10,063,275
2,726,895(Indirect)
View


2015-09-28Sale
2015-09-306:45 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Deerfield Special Situations Fund L.P.Other10% Owner
1,828,529
$1.795
$3,281,995
7,490,126(Indirect)
View


2015-09-22Purchase
2015-09-2210:48 am
Regenxbio Inc.
RGNX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield International Master Fund L.P.Deerfield Partners LpOther10% Owner
175,000
$22
$3,850,000
1,256,542(Indirect)
View


2015-07-17Sale
2015-07-215:36 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
231,793
$2.172
$503,414
7,838,226(Indirect)
View


2015-07-06Sale
2015-07-085:28 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
834,505
$2.077
$1,733,354
8,354,740(Indirect)
View


2015-06-29Sale
2015-07-016:01 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
713,222
$2.091
$1,491,582
8,678,580(Indirect)
View


2015-06-24Sale(A)
2015-07-015:54 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
354,534
$2.243
$795,197
8,807,597(Indirect)
View


2015-06-24Sale
2015-06-265:05 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
756,852
$2.266
$1,715,004
9,027,951(Indirect)
View


2015-06-19Sale
2015-06-235:12 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
499,895
$2.385
$1,192,395
9,249,660(Indirect)
View


2015-06-16Sale
2015-06-185:48 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
478,366
$2.435
$1,164,894
9,496,683(Indirect)
View


2015-06-11Sale
2015-06-158:20 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
748,030
$2.441
$1,825,829
9,821,484(Indirect)
View


2015-03-06Sale
2015-03-093:23 pm
Ehealth Inc.
EHTH
Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
1,342,573
$9.52
$12,781,296
1,342,573(Indirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
67,448
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
1,182,941
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,996
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,998
$0
1,623,089(Indirect)
View


2015-09-03Purchase
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,996
$21.01
1,623,089(Indirect)
View


2015-09-03Purchase
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,998
$21.01
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
67,448
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
1,182,941
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,996
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,998
$0
1,623,089(Indirect)
View


2015-09-22Conversion
2015-09-2210:48 am
N/AN/A
Regenxbio Inc.
RGNX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield International Master Fund L.P.Deerfield Partners LpOther10% Owner
771,963
$0
1,256,542(Indirect)
View


2015-09-22Conversion
2015-09-2210:48 am
N/AN/A
Regenxbio Inc.
RGNX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield International Master Fund L.P.Deerfield Partners LpOther10% Owner
397,079
$0
1,256,542(Indirect)
View


2015-09-22Conversion
2015-09-2210:48 am
N/AN/A
Regenxbio Inc.
RGNX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield International Master Fund L.P.Deerfield Partners LpOther10% Owner
771,963
$0
1,256,542(Indirect)
View


2015-09-22Conversion
2015-09-2210:48 am
N/AN/A
Regenxbio Inc.
RGNX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield International Master Fund L.P.Deerfield Partners LpOther10% Owner
397,079
$0
1,256,542(Indirect)
View


2015-05-05Equity Swap
2015-05-071:38 pm
N/AN/A
Auspex Pharmaceuticals Inc.
ASPX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Private Design International II L.P.Other10% Owner
490,069
$0
0(Indirect)
View


2015-05-05Equity Swap
2015-05-071:38 pm
N/AN/A
Auspex Pharmaceuticals Inc.
ASPX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Private Design International II L.P.Other10% Owner
953,286
$0
0(Indirect)
View


2015-05-05Equity Swap
2015-05-071:38 pm
N/AN/A
Auspex Pharmaceuticals Inc.
ASPX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Private Design International II L.P.Other10% Owner
1,182,943
$0
0(Indirect)
View


2015-05-05Equity Swap
2015-05-071:38 pm
N/AN/A
Auspex Pharmaceuticals Inc.
ASPX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Private Design International II L.P.Other10% Owner
849,426
$0
0(Indirect)
View


2015-05-05Equity Swap
2015-05-071:38 pm
N/AN/A
Auspex Pharmaceuticals Inc.
ASPX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Private Design International II L.P.Other10% Owner
973,379
$0
0(Indirect)
View


2015-01-29Equity Swap
2015-02-025:02 pm
N/AN/A
Auxilium Pharmaceuticals Inc
AUXL
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
2,797,408
$0
0(Indirect)
View


2015-01-29Equity Swap
2015-02-025:02 pm
N/AN/A
Auxilium Pharmaceuticals Inc
AUXL
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
3,469,974
$0
0(Indirect)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 07:54:52 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  











Insider Trading - Deerfield Special Situations Fund L.P. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Deerfield Special Situations Fund L.P.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In


Goto page 0,
1,
Next
Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-12-12Sale
2016-12-1412:48 pm
Invuity Inc.
IVTY
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Other10% Owner
184,796
$6.217
$1,148,909
1,807,239(Indirect)
View


2016-09-22Sale
2016-09-265:29 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners L.P.Deerfield Special Situations Fund L.P.Other10% Owner
1,120,461
$16.56
$18,559,971
2,383,955(Indirect)
View


2016-09-15Sale
2016-09-196:42 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners L.P.Deerfield Special Situations Fund L.P.Other10% Owner
547,886
$15.66
$8,582,621
2,660,207(Indirect)
View


2016-07-20Sale
2016-08-017:14 pm
Zafgen Inc
ZFGN
Flynn James EDeerfield Mgmt L.P.Deerfield Partners L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Special Situations Fund L.P.Other10% Owner
1,341,499
$3.312
$4,442,776
1,151,802(Indirect)
View


2016-07-25Purchase
2016-07-2512:19 pm
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
400,000
$15
$6,000,000
889,230(Indirect)
View


2016-07-21Sale
2016-07-214:26 pm
Axogen Inc.
AXGN
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Other10% Owner
102,136
$6.7
$684,311
3,000,000(Indirect)
View


2016-07-14Sale
2016-07-186:20 pm
Axogen Inc.
AXGN
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Other10% Owner
279,303
$7.534
$2,104,171
3,175,349(Indirect)
View


2016-07-06Purchase
2016-07-0611:54 am
Syros Pharmaceuticals Inc.
SYRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
400,000
$12.5
$5,000,000
1,466,654(Indirect)
View


2016-06-20Sale
2016-06-224:32 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
204,854
$14.21
$2,911,063
1,062,874(Indirect)
View


2016-06-14Sale
2016-06-165:37 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
43,300
$13.88
$601,169
1,062,874(Indirect)
View


2016-06-06Sale
2016-06-085:17 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
63,736
$13.92
$887,049
1,062,874(Indirect)
View


2016-05-31Sale
2016-06-025:17 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
99,508
$13.85
$1,378,435
1,073,157(Indirect)
View


2016-05-25Sale
2016-05-275:18 pm
Ehealth Inc.
EHTH
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners L.P.Deerfield International Master Fund L.P.Other10% Owner
212,581
$14.13
$3,002,906
1,296,606(Indirect)
View


2015-09-03Purchase
2016-02-1912:38 pm
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
750,317
$19.47
$14,605,330
1,623,089(Indirect)
View


2016-02-12Purchase
2016-02-172:02 pm
Zafgen Inc
ZFGN
Flynn James EDeerfield Mgmt L.P.Deerfield Partners LpDeerfield Management CoDeerfield International Master Fund L.P.Deerfield Special Situations Fund L.P.Other10% Owner
64,545
$6.247
$403,187
2,053,232(Indirect)
View


2016-02-09Purchase
2016-02-118:21 pm
Zafgen Inc
ZFGN
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
267,493
$6.018
$1,609,668
2,039,360(Indirect)
View


2016-01-20Purchase
2016-01-224:16 pm
Xenoport Inc
XNPT
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Other10% Owner
346,417
$4.095
$1,418,404
6,667,391(Indirect)
View


2015-12-16Purchase
2015-12-187:43 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners LpDeerfield Special Situations Fund L.P.Other10% Owner
11,170
$8.967
$100,156
2,740,122(Indirect)
View


2015-12-09Purchase(A)
2015-12-187:40 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners LpDeerfield Special Situations Fund L.P.Other10% Owner
425,982
$8.604
$3,665,308
2,735,681(Indirect)
View


2015-12-15Sale
2015-12-177:00 pm
Streamline Health Solutions Inc
STRM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Other10% Owner
397,259
$1.229
$488,285
2,217,964(Indirect)
View


2015-12-09Purchase
2015-12-116:06 pm
Vanda Pharmaceuticals Inc.
VNDA
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield International Master Fund L.P.Deerfield Partners LpDeerfield Special Situations Fund L.P.Other10% Owner
1,201,364
$8.377
$10,063,275
2,726,895(Indirect)
View


2015-12-04Purchase
2015-12-086:35 pm
Alimera Sciences Inc
ALIM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield Private Design International II L.P.Other10% Owner
272,249
$3.01
$819,578
4,760,408(Indirect)
View


2015-12-01Purchase
2015-12-036:14 pm
Alimera Sciences Inc
ALIM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield Private Design International II L.P.Other10% Owner
243,252
$2.999
$729,477
4,624,284(Indirect)
View


2015-11-06Purchase
2015-11-104:12 pm
Alimera Sciences Inc
ALIM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield Private Design International II L.P.Other10% Owner
73,250
$2.983
$218,483
4,502,658(Indirect)
View


2015-10-30Purchase
2015-11-035:22 pm
Alimera Sciences Inc
ALIM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield Private Design International II L.P.Other10% Owner
16,542
$3
$49,626
4,466,033(Indirect)
View


2015-10-27Purchase
2015-10-296:05 pm
Alimera Sciences Inc
ALIM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield Private Design International II L.P.Other10% Owner
59,342
$2.996
$177,763
4,457,762(Indirect)
View


2015-10-22Purchase
2015-10-265:48 pm
Alimera Sciences Inc
ALIM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield Private Design International II L.P.Other10% Owner
60,364
$3
$181,113
4,428,091(Indirect)
View


2015-10-19Purchase
2015-10-216:55 pm
Alimera Sciences Inc
ALIM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield Private Design International II L.P.Other10% Owner
390,040
$2.974
$1,159,854
4,397,909(Indirect)
View


2015-10-14Purchase
2015-10-1412:34 pm
Cytomx Therapeutics Inc.
CTMX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
625,000
$12
$7,500,000
671,024(Indirect)
View


2015-10-07Purchase
2015-10-099:39 pm
Alimera Sciences Inc
ALIM
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund II L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Deerfield Private Design International II L.P.Other10% Owner
321,785
$2.424
$779,951
4,202,889(Indirect)
View


2015-09-28Sale
2015-09-306:45 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Partners LpDeerfield International Master Fund L.P.Deerfield Special Situations Fund L.P.Other10% Owner
1,828,529
$1.795
$3,281,995
7,490,126(Indirect)
View


2015-09-18Sale
2015-09-221:05 pm
Axogen Inc.
AXGN
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Other10% Owner
345,000
$5.501
$1,897,983
3,381,439(Indirect)
View


2015-07-28Purchase
2015-07-2811:55 am
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
400,000
$15
$6,000,000
429,166(Indirect)
View


2015-07-28Sale
2015-07-2811:55 am
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
166,666
$15
$2,499,990
429,166(Indirect)
View


2015-06-29Sale
2015-07-016:01 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
713,222
$2.091
$1,491,582
8,678,580(Indirect)
View


2015-06-24Sale(A)
2015-07-015:54 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
354,534
$2.243
$795,197
8,807,597(Indirect)
View


2015-06-24Sale
2015-06-265:05 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
756,852
$2.266
$1,715,004
9,027,951(Indirect)
View


2015-06-23Purchase
2015-06-253:14 pm
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
250,000
$14
$3,500,000
1,124,740(Indirect)
View


2015-06-19Sale
2015-06-235:12 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
499,895
$2.385
$1,192,395
9,249,660(Indirect)
View


2015-06-16Sale
2015-06-185:48 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
478,366
$2.435
$1,164,894
9,496,683(Indirect)
View


2015-06-11Sale
2015-06-158:20 pm
Antares Pharma Inc
ATRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Other10% Owner
748,030
$2.441
$1,825,829
9,821,484(Indirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-07-25Conversion
2016-07-2512:19 pm
N/AN/A
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
535,996
$0
889,230(Indirect)
View


2016-07-25Conversion
2016-07-2512:19 pm
N/AN/A
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
267,998
$0
889,230(Indirect)
View


2016-07-25Conversion
2016-07-2512:19 pm
N/AN/A
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
99,830
$0
889,230(Indirect)
View


2016-07-25Conversion
2016-07-2512:19 pm
N/AN/A
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
99,830
$0
889,230(Indirect)
View


2016-07-25Conversion
2016-07-2512:19 pm
N/AN/A
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
535,996
$0
889,230(Indirect)
View


2016-07-25Conversion
2016-07-2512:19 pm
N/AN/A
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
267,998
$0
889,230(Indirect)
View


2016-07-25Conversion
2016-07-2512:19 pm
N/AN/A
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
99,830
$0
889,230(Indirect)
View


2016-07-25Conversion
2016-07-2512:19 pm
N/AN/A
Audentes Therapeutics Inc.
BOLD
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
99,830
$0
889,230(Indirect)
View


2016-07-06Conversion
2016-07-0611:54 am
N/AN/A
Syros Pharmaceuticals Inc.
SYRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
1,186,654
$0
1,466,654(Indirect)
View


2016-07-06Conversion
2016-07-0611:54 am
N/AN/A
Syros Pharmaceuticals Inc.
SYRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
508,566
$0
1,466,654(Indirect)
View


2016-07-06Conversion
2016-07-0611:54 am
N/AN/A
Syros Pharmaceuticals Inc.
SYRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
1,186,654
$0
1,466,654(Indirect)
View


2016-07-06Conversion
2016-07-0611:54 am
N/AN/A
Syros Pharmaceuticals Inc.
SYRS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
508,566
$0
1,466,654(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
67,448
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
1,182,941
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,996
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,998
$0
1,623,089(Indirect)
View


2015-09-03Purchase
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,996
$21.01
1,623,089(Indirect)
View


2015-09-03Purchase
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,998
$21.01
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
67,448
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
1,182,941
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,996
$0
1,623,089(Indirect)
View


2015-09-03Conversion
2016-02-1912:38 pm
N/AN/A
Avexis Inc.
AVXS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Partners LpDeerfield International Master Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.DirectorOther10% Owner
117,998
$0
1,623,089(Indirect)
View


2015-10-14Conversion
2015-10-1412:34 pm
N/AN/A
Cytomx Therapeutics Inc.
CTMX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
160,512
$0
671,024(Indirect)
View


2015-10-14Conversion
2015-10-1412:34 pm
N/AN/A
Cytomx Therapeutics Inc.
CTMX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
160,512
$0
671,024(Indirect)
View


2015-10-14Conversion
2015-10-1412:34 pm
N/AN/A
Cytomx Therapeutics Inc.
CTMX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
160,512
$0
671,024(Indirect)
View


2015-10-14Conversion
2015-10-1412:34 pm
N/AN/A
Cytomx Therapeutics Inc.
CTMX
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
160,512
$0
671,024(Indirect)
View


2015-07-28Conversion
2015-07-2811:55 am
N/AN/A
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
208,333
$0
429,166(Indirect)
View


2015-07-28Conversion
2015-07-2811:55 am
N/AN/A
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
208,333
$0
429,166(Indirect)
View


2015-07-28Exercise
2015-07-2811:55 am
N/AN/A
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
104,166
$12
429,166(Indirect)
View


2015-07-28Exercise
2015-07-2811:55 am
N/AN/A
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
104,166
$12
429,166(Indirect)
View


2015-07-28Conversion
2015-07-2811:55 am
N/AN/A
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
500,000
$0
429,166(Indirect)
View


2015-07-28Conversion
2015-07-2811:55 am
N/AN/A
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
500,000
$0
429,166(Indirect)
View


2015-07-28Exercise
2015-07-2811:55 am
N/AN/A
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
104,166
$0
429,166(Indirect)
View


2015-07-28Exercise
2015-07-2811:55 am
N/AN/A
Neos Therapeutics Inc.
NEOS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Mgmt III L.P.Deerfield Private Design Fund III L.P.Other10% Owner
104,166
$0
429,166(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
696,993
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
301,027
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
484,944
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
375,592
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
430,399
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
133,597
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
18,825
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
29,755
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
282,984
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
324,278
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
2,013,613
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
869,667
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
1,401,003
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
1,085,085
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
1,243,423
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
385,962
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
54,385
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
85,962
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
817,541
$0
1,124,740(Indirect)
View


2015-06-23Conversion
2015-06-253:14 pm
N/AN/A
Nivalis Therapeutics Inc.
NVLS
Flynn James EDeerfield Mgmt L.P.Deerfield Management CoDeerfield Special Situations Fund L.P.Deerfield Private Design Fund L PDeerfield Private Design Fund II L.P.Deerfield Private Design International L.P.Deerfield Private Design International II L.P.Other10% Owner
936,839
$0
1,124,740(Indirect)
View





Goto page 0,
1,
Next





    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 07:54:52 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  











 SECGems: Deerfield Special Situations International Master Fund, L.P. 







































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  






























 Deerfield Special Situations International Master Fund, L.P. 
		     










 Info




 Ownership




 Filings
20













	 
	
	 780 THIRD AVENUE, 37TH FLOOR
	 
	
	
	   NEW YORK, 
	   NY, 
	  
	
	  
		
		

			
			 
		
		
		
		 USA
		
	
	   212-692-7108    
	    

						        









Filing DateCurrent and former namesChanged on date




2012-12-20Deerfield Special Situations International Master Fund, L.P.








Central Index Key (CIK)
0001565099
Fiscal year end
1231










Ownership (Form 3,4,5)# Filings





 DEERFIELD MANAGEMENT CO (0001009258) 


16




 DEERFIELD MANAGEMENT CO /NY (0001009258) 


3




 DEERFIELD PARTNERS LP (0001301041) 


4




 Deerfield International Master Fund LP (0001565089) 


4




 Deerfield Mgmt III LP (0001610540) 


4




 Deerfield Mgmt LP (0001010823) 


20




 Deerfield Private Design Fund II LP (0001483687) 


8




 Deerfield Private Design Fund III LP (0001603333) 


4




 Deerfield Private Design International II LP (0001483686) 


4




 Deerfield Private Design International II Ltd (0001507784) 


4




 Deerfield Special Situations Fund LP (0001354395) 


20




 Flynn James E (0001352546) 


20











All related persons/companies# Filings





 Auspex Pharmaceuticals, Inc. (0001454189) 


2




 Avalanche Biotechnologies, Inc. (0001501756) 


2




 CAS MEDICAL SYSTEMS INC (0000764579) 


2




 DEERFIELD CAPITAL LP ET AL


20




 DEERFIELD MANAGEMENT CO (0001009258) 


16




 DEERFIELD MANAGEMENT CO /NY (0001009258) 


19




 DEERFIELD PARTNERS, LP (0001301041) 


4




 Deerfield International Master Fund, L.P. (0001565089) 


4




 Deerfield Mgmt III, L.P. (0001610540) 


4




 Deerfield Mgmt L.P. (0001010823) 


20




 Deerfield Private Design Fund II, L.P. (0001483687) 


8




 Deerfield Private Design Fund III, L.P. (0001603333) 


4




 Deerfield Private Design International II, L.P. (0001483686) 


4




 Deerfield Private Design International II, Ltd. (0001507784) 


4




 Deerfield Special Situations Fund, L.P. (0001354395) 


20




 Dicerna Pharmaceuticals Inc (0001399529) 


4




 Flynn James E (0001352546) 


20




 Loxo Oncology, Inc. (0001581720) 


3




 NxStage Medical, Inc. (0001333170) 


1




 PROTEON THERAPEUTICS INC (0001359931) 


2




 Somaxon Pharmaceuticals, Inc. (0001339455) 


1




 TV2 HOLDING Co


2




 TriVascular Technologies, Inc. (0001432732) 


2




 Vanda Pharmaceuticals Inc. (0001347178) 


1







 








db
 
 










































Deerfield International Master Fund, L.P. - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Deerfield International Master Fund, L.P.
Check out list of companies and businesses related to Deerfield International Master Fund, L.P.. Find out Deerfield International Master Fund, L.P. address and contact details. View other people related to Deerfield International Master Fund, L.P. - coworkers, colleagues, companions, etc.
Address:   

780 3RD AVENUE 37TH FLOOR NEW YORK 10017 NY




Companies related to Deerfield International Master Fund, L.P.
CIKCompany NamePositionCompany Address0001333493eHealth, Inc.440 EAST MIDDLEFIELD ROAD  MOUNTAIN VIEW 940430001347178Vanda Pharmaceuticals Inc.2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON 20037




Deerfield International Master Fund, L.P. on the Web
Persons related to Deerfield International Master Fund, L.P. - eHealth, Inc.NamePositionCitySTEVEN  CAKEBREADSAN FRANCISCOSTEVEN  CAKEBREADDirector SAN FRANCISCOSTEVEN  CAKEBREADDirector SAN FRANCISCOArthur Bruce  CohenNORWALKArthur Bruce  CohenNORWALKArthur Bruce  CohenNORWALKArthur Bruce  CohenNEW YORKSUISSE/  CREDIT10% Owner NEW YORK, NY 10010RAYMOND  DEBBANENEW YORKRAYMOND  DEBBANEBALTIMOREDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO  DEERFIELDNEW YORKMANAGEMENT CO /NY  DEERFIELD10% Owner Deerfield Mgmt L.P.NEW YORKDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKRobert L  FahlmanSr VP, Carrier Relations & COO MOUNTAIN VIEWRobert L  FahlmanSr.VP, Carrier Relations & COO MOUNTAIN VIEWRobert L  FahlmanMOUNTAIN VIEWScott N  FlandersChief Executive Officer CARYScott N  FlandersDirector IRVINEScott N  FlandersDirector MOUNTAIN VIEWJames E  Flynn10% Owner NEW YORKJames E  Flynn10% Owner NEW YORKDavid K.  FrancisChief Financial Officer MOUNTAIN VIEWSamuel C  Gibbs IIISenior Vice President MOUNTAIN VIEWSamuel C  Gibbs IIIPres., eHealth Gov. Systems MOUNTAIN VIEWSamuel C  Gibbs IIISenior Vice President MOUNTAIN VIEWMichael  GoldbergDirector MENLO PARKMichael  GoldbergDirector MENLO PARKMichael  GoldbergDirector MENLO PARKMichael  GoldbergDirector MOUNTAIN VIEWTimothy C.  HannanChief Marketing Officer MOUNTAIN VIEWJoseph Patrick  HealeyNEW YORKJoseph Patrick  HealeyNEW YORKHealthCor Associates, LLCNEW YORKHealthCor Associates, LLCNEW YORKHealthCor Capital, L.P.NEW YORKHealthCor Capital, L.P.NEW YORKHealthCor Group, LLCNEW YORKOHealthCor Group, LLCNEW YORKHealthCor Group, LLCNEW YORKHealthCor Hybrid Offshore GP, LLCNEW YORKHealthCor Hybrid Offshore GP, LLCNEW YORKHEALTHCOR HYBRID OFFSHORE LTDNEW YORKHEALTHCOR HYBRID OFFSHORE LTDNEW YORKHealthCor Hybrid Offshore Master Fund, L.P.NEW YORKHealthCor Hybrid Offshore Master Fund, L.P.NEW YORKHEALTHCOR L PNEW YORKHEALTHCOR L PNEW YORKHEALTHCOR L PNEW YORKHealthCor Long Master GP LLCNEW YORKHealthCor Long Master GP LLCNEW YORKHealthCor Long OffShore Master Fund LPNEW YORKHealthCor Long OffShore Master Fund LPNEW YORKHealthCor Management, L.P.10% Owner NEW YORKHealthCor Management, L.P.10% Owner NEW YORKHealthCor Offshore GP, LLCNEW YORKHealthCor Offshore GP, LLCNEW YORKHealthCor Offshore GP, LLCNEW YORKHEALTHCOR OFFSHORE LTDNEW YORKHEALTHCOR OFFSHORE LTDNEW YORKHealthCor Offshore Master Fund, L.P.NEW YORKHealthCor Offshore Master Fund, L.P.NEW YORKLAWRENCE M  HIGBYDirector NEWPORT BEACHLAWRENCE M  HIGBYDirector MOUNTAIN VIEWThomas R  HitchnerBALTIMOREThomas R  HitchnerBALTIMOREStuart  HuizingaSr. VP & CFO MOUNTAIN VIEWStuart  HuizingaSr. VP & CFO MOUNTAIN VIEWStuart  HuizingaSr. VP & CFO MOUNTAIN VIEWStuart  HuizingaSr. VP & CFO MOUNTAIN VIEWRobert S  HurleyPresident, Medicare Products MOUNTAIN VIEWRobert S  HurleySr. VP, Carrier Relations MOUNTAIN VIEWCV  Invus,NEW YORKCV  Invus,BALTIMOREInvus Group, LLCNEW YORKInvus Group, LLCBALTIMOREJay Walter  JenningsSVP, Finance and APO MOUNTAIN VIEWKLEINER PERKINS CAUFIELD & BYERS IX A LP10% Owner MENLO PARKKLEINER PERKINS CAUFIELD & BYERS IX B LP10% Owner MENLO PARKKPCB IX ASSOCIATES LLC10% Owner MENLO PARKJOSEPH  LACOBDirector MENLO PARKJOSEPH  LACOBDirector MENLO PARKKATHLEEN  LAPORTENEW YORKGary L  LauerChr. of the Board and CEO MOUNTAIN VIEWRANDALL S  LIVINGSTONDirector STANFORDRANDALL S  LIVINGSTONDirector STANFORDRANDALL S  LIVINGSTONDirector WOODSIDEJack L  Oliver IIIDirector CAPE GIRARDEAUJack L  Oliver IIICAPE GURARDEAUJack L  Oliver IIIDirector CAPE GIRARDEAUJack L  Oliver IIIDirector MOUNTAIN VIEWPatel Family Trust U/A/D 12/08/1995ENCINITASSharon Lynn  PatelENCINITASVipool Mohanlal  PatelENCINITASVipool Mohanlal  Patel10% Owner ENCINITASQUESTMARK ADVISERS LLCQUESTMARK ADVISERS LLCBALTIMOREQUESTMARK PARTNERS LP10% Owner QUESTMARK PARTNERS LPBALTIMOREQUESTMARK PARTNERS SIDE FUND LPQUESTMARK PARTNERS SIDE FUND LPBALTIMOREScott  SanbornChief Marketing & Rev. Officer MOUNTAIN VIEWSheryl  SandbergMOUNTAIN VIEWSheryl  SandbergDirector MOUNTAIN VIEWSheryl  SandbergDirector PALO ALTOCHRISTOPHER J  SCHAEPEDirector MENLO PARKBenjamin S  SchapiroBALTIMOREBenjamin S  SchapiroBALTIMOREWilliam T  ShaughnessyPresident and COO MOUNTAIN VIEWEllen O.  TauscherDirector ELYRIAEllen O.  TauscherDirector MOUNTAIN VIEWBruce  TelkampExecutive Vice President MOUNTAIN VIEWBruce  TelkampSr VP, Gen. Counsel & Secrty. MOUNTAIN VIEWBruce  TelkampExecutive Vice President MOUNTAIN VIEWBruce  TelkampExecutive Vice President MOUNTAIN VIEWTom G.  TsaoPresident, Small Business MOUNTAIN VIEWUlys, LLCNEW YORKUlys, LLCBALTIMORESheldon  WangExecutive VP, Technology MOUNTAIN VIEWSheldon  WangSr VP and Chief Tech. Officer MOUNTAIN VIEWSheldon  WangSr. VP and Chief Tech. Officer MOUNTAIN VIEWSheldon  WangExecutive VP, Technology MOUNTAIN VIEWSheldon  WangExec. VP Technology MOUNTAIN VIEWWeiss, Peck & Greer Venture Associates IV Cayman, L.P.MENLO PARKWeiss, Peck & Greer Venture Associates IV, L.L.C.MENLO PARK,WEISS PECK & GREER VENTURE ASSOCIATES V-A LLCMENLO PARKWeiss, Peck & Greer Venture Associates V Cayman, L.P.MENLO PARKWEISS PECK & GREER VENTURE ASSOCIATES V LLCMENLO PARKWPG Enterprise Fund III, L.L.C.MENLO PARK,WPG Information Sciences Entrepreneur Fund II-A, L.L.CMENLO PARKWPG Information Sciences Entrepreneur Fund II, L.L.CMENLO PARKWPG INFORMATION SCIENCES ENTREPRENEUR FUND LPMENLO PARKWPG VC FUND ADVISER II, L.L.C.MENLO PARKWPG VC Fund Adviser, L.L.C.MENLO PARKPersons related to Deerfield International Master Fund, L.P. - Vanda Pharmaceuticals Inc.NamePositionCityALEXANDER E  BARKASPALO ALTOPaolo  BaroldiSVP & Chief Medical Officer ROCKVILLEPaolo  BaroldiSVP & Chief Medical Officer WASHINGTONKENNETH  BATEDirector CAMBRIDGE,Bio One Capital Pte Ltd.SINGAPOREBio One Capital Pte Ltd.CENTROSBiomedical Sciences Investment Fund Pte Ltd.10% Owner SINGAPOREBiomedical Sciences Investment Fund Pte Ltd.10% Owner CENTROSGunther  BirznieksWASHINGTONJAMES C  BLAIR10% Owner PRINCETONCARE CAPITAL  II  LLC10% Owner PRINCETONCARE CAPITAL  II  LLC10% Owner PRINCETONCARE CAPITAL INVESTMENTS II LPPRINCETONCARE CAPITAL INVESTMENTS II LPPRINCETONCare Capital Offshore Investments II LPPRINCETONCare Capital Offshore Investments II LPPRINCETONWilliam D  ClarkROCKVILLEWilliam D  ClarkSr. VP, Chief Business Officer ROCKVILLEMICHAEL F  COLADirector WAYNEMICHAEL F  COLADirector WASHINGTONThomas Lyle  CopmannROCKVILLEDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO  DEERFIELDNEW YORKMANAGEMENT CO /NY  DEERFIELDDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.10% Owner PRINCETONRICHARD W  DUGANDirector GERMANTOWNRICHARD W  DUGANDirector SCOTTSDALERICHARD W  DUGANDirector GIBSONIA, PA 15044EDB Investments Pte Ltd.SINGAPOREEDB Investments Pte Ltd.CENTROSJohn Joseph  FeeneySVP & Chief Medical Officer ROCKVILLEJohn Joseph  FeeneyWASHINGTONJames E  Flynn10% Owner NEW YORKJames E  Flynn10% Owner NEW YORKSteven K  GalsonDirector ROCKVILLESteven K  GalsonDirector WASHINGTONAlbert W.  GianchettiSr.VP,Chief Commercial Officer ROCKVILLEThomas Edward  GibbsSVP, Chief Commercial Officer WASHINGTONRichard L.  GulinoSVP, General Counsel & Sec. WASHINGTONBrian K  HalakDirector PRINCETONRUSSELL C  HIRSCHPALO ALTOWAYNE T  HOCKMEYERDirector GAITHERSBURGStephanie Rast  IrishActing CFO/Treasurer ROCKVILLEHABIB  KAIROUZNEW YORKHABIB  KAIROUZNEW YORKARGERIS N  KARABELASDirector PRINCETONJames Patrick  KellyEVP & Chief Financial Officer ROCKVILLEJames Patrick  KellySVP, CFO, Sec & Treasurer WASHINGTONJAN  LESCHLYPRINCETONJAN  LESCHLYPRINCETONMARK  LESCHLYNEW YORKMARK  LESCHLYNEW YORKMEDIMMUNE INC /DE10% Owner GAITHERSBURGVINCENT  MILANODirector VINCENT  MILANODirector EXTONVINCENT  MILANODirector WASHINGTONROBERT J  MORE10% Owner PRINCETONDeepak Shripad  PhadkeVice President Manufacturing ROCKVILLEHOWARD H  PIENDirector EMERYVILLEHOWARD H  PIENDirector ROCKVILLEMihael Hristos  PolymeropoulosPresident and CEO ROCKVILLEMihael Hristos  PolymeropoulosPresident and CEO WASHINGTONPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLC10% Owner PALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTODavid Russ  RamsayDirector PRINCETONDavid Russ  RamsayDirector PRINCETONRobert  RepellaSVP & Chief Commercial Officer ROCKVILLERobert  RepellaSVP & Chief Commercial Officer WASHINGTONGian Piero  ReverberiSVP & Chief Commercial Officer WASHINGTONRHO CAPITAL PARTNERS INCNEW YORKRHO CAPITAL PARTNERS INCNEW YORKCAPITAL PARTNERS VERWALTUNGS GMBH  RHONEW YORKCAPITAL PARTNERS VERWALTUNGS GMBH  RHONEW YORKRHO MANAGEMENT TRUST INEW YORKRHO MANAGEMENT TRUST INEW YORKRHO MANAGEMENT VENTURES IV LLCNEW YORKRHO MANAGEMENT VENTURES IV LLCNEW YORKRHO VENTURES IV GMBH & CO BETEILIGUNGS KGNEW YORKRHO VENTURES IV GMBH & CO BETEILIGUNGS KGNEW YORKRHO VENTURES IV LP10% Owner NEW YORKRHO VENTURES IV LP10% Owner NEW YORKRHO VENTURES IV QP LPNEW YORKRHO VENTURES IV QP LPNEW YORKJOSHUA  RUCHNEW YORKJOSHUA  RUCHNEW YORKDAVID  SCHNELLPALO ALTOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONSTEVEN A  SHALLCROSSSr. VP, CFO, Treasurer ROCKVILLESTEVEN A  SHALLCROSSSr. VP, CFO, Treasurer ROCKVILLEJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector PALO ALTOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL PARTNERS LPSAN DIEGOKEVIN C  TANG10% Owner SAN DIEGOJESSE I  TREU10% Owner PRINCETONNICOLE  VITULLO10% Owner PRINCETONThomas  WatkinsDirector ROCKVILLEThomas  WatkinsDirector LAKE FOREST
Potentially same personNameCityCountryDeerfield International Master Fund, L.P.NEW YORKNY












 









Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












 SECGems: Deerfield International Master Fund, L.P. 







































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  






























 Deerfield International Master Fund, L.P. 
		     










 Info




 Ownership




 Filings
56













	 
	
	 780 THIRD AVENUE, 37TH FLOOR
	 
	
	
	   NEW YORK, 
	   NY, 
	  
	
	  
		
		

			
			 
		
		
		
		 USA
		
	
	   212-692-7108    
	    

						        









Filing DateCurrent and former namesChanged on date




2012-12-20Deerfield International Master Fund, L.P.








Central Index Key (CIK)
0001565089
Fiscal year end
1231










Ownership (Form 3,4,5)# Filings





 DEERFIELD MANAGEMENT CO (0001009258) 


53




 DEERFIELD MANAGEMENT CO /NY (0001009258) 


1




 DEERFIELD PARTNERS LP (0001301041) 


56




 Deerfield Mgmt III LP (0001610540) 


3




 Deerfield Mgmt LP (0001010823) 


53




 Deerfield Private Design Fund II LP (0001483687) 


3




 Deerfield Private Design Fund III LP (0001603333) 


3




 Deerfield Private Design International II LP (0001483686) 


3




 Deerfield Special Situations Fund LP (0001354395) 


37




 Deerfield Special Situations International Master Fund LP (0001565099) 


4




 Flynn James E (0001352546) 


53











All related persons/companies# Filings





 ANTARES PHARMA  INC (0001016169) 


11




 ANTARES PHARMA INC /MN/


11




 ANTARES PHARMA, INC. (0001016169) 


11




 AUXILIUM PHARMACEUTICALS INC (0001182129) 


5




 Auspex Pharmaceuticals, Inc. (0001454189) 


3




 Avalanche Biotechnologies, Inc. (0001501756) 


1




 AveXis, Inc. (0001652923) 


2




 DEERFIELD CAPITAL LP ET AL


53




 DEERFIELD MANAGEMENT CO (0001009258) 


53




 DEERFIELD MANAGEMENT CO /NY (0001009258) 


54




 DEERFIELD PARTNERS, LP (0001301041) 


56




 Deerfield Mgmt III, L.P. (0001610540) 


3




 Deerfield Mgmt L.P. (0001010823) 


53




 Deerfield Private Design Fund II, L.P. (0001483687) 


3




 Deerfield Private Design Fund III, L.P. (0001603333) 


3




 Deerfield Private Design International II, L.P. (0001483686) 


3




 Deerfield Special Situations Fund, L.P. (0001354395) 


37




 Deerfield Special Situations International Master Fund, L.P. (0001565099) 


4




 Flynn James E (0001352546) 


53




 Loxo Oncology, Inc. (0001581720) 


1




 NxStage Medical, Inc. (0001333170) 


1




 REGENXBIO Inc. (0001590877) 


1




 ReGenX Biosciences, LLC


1




 Recro Pharma, Inc. (0001588972) 


3




 Vanda Pharmaceuticals Inc. (0001347178) 


8




 XENOPORT INC (0001130591) 


3




 ZAFGEN, INC. (0001374690) 


4




 eHealth, Inc. (0001333493) 


13







 








db
 
 












































	Deerfield | Deerfield Investments









































HOME
INVESTMENT
INSTITUTE
FOUNDATION

NEWS AND EVENTS

CONTACT US














INVESTMENT OUR FINANCING PARTNERS INVESTMENT TEAM










We make healthcare progress possible by connecting capital to opportunity.

Companies in the healthcare field face a myriad of financing challenges. What is the optimal funding strategy for an acquisition? How can the development and launch of new products or services be paid for more creatively? What approaches can be taken to improve balance sheet flexibility or limit equity dilution? Too often the options are formulaic and inflexible.


At Deerfield, our comprehensive understanding of healthcare assets allows us to appreciate opportunity even when complex financial, legislative, regulatory and competitive pressures are present. Collaboration, intellectual curiosity and pragmatism define our approach. We craft flexible, tailored and often unexpected financing options, exploring every angle so that companies can execute their business strategy to the fullest.

























Our expertise

We specialize in diverse financing challenges. Below is a sampling of our expertise. Click on each to find out more about some of our corporate partners.












Our Strategies

We launched in 1994 with $17 million in equity. Today, we manage funds in excess of $6 billion. A portion of all profits from the Deerfield funds are donated to the Deerfield Foundation, including all profits from selected funds.

Public investments

We invest broadly in public healthcare securities, with no restrictions on the size of the company or in the type of security. We typically own equity or debt interests in over 100 companies.
Private Investments

We custom design transactions to accommodate long-term structured investments in private and public healthcare companies.









Our Financing PARTNERS

We work with companies from across the breadth of the healthcare spectrum, from early stage drug research businesses to mature healthcare service and medical device companies. For a full list of our partners, click here.




 















© 2017 Deerfield. All rights reserved | Contact | Terms of Use | Privacy Policy















Deerfield International Master Fund, L.P. - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Deerfield International Master Fund, L.P.
Check out list of companies and businesses related to Deerfield International Master Fund, L.P.. Find out Deerfield International Master Fund, L.P. address and contact details. View other people related to Deerfield International Master Fund, L.P. - coworkers, colleagues, companions, etc.
Address:   

780 THIRD AVENUE, 37TH FLOOR  NEW YORK 10017 NY




Companies related to Deerfield International Master Fund, L.P.
CIKCompany NamePositionCompany Address0001016169ANTARES PHARMA, INC.100 PRINCETON SOUTH SUITE 300 EWING 086280001130591XENOPORT INC2000 SEAPORT BLVD., SUITE 300  REDWOOD CITY 940630001182129AUXILIUM PHARMACEUTICALS INC640 LEE ROAD  CHESTERBROOK 190870001333170NxStage Medical, Inc.350 MERRIMACK STREET  LAWRENCE 018430001333493eHealth, Inc.440 EAST MIDDLEFIELD ROAD  MOUNTAIN VIEW 940430001347178Vanda Pharmaceuticals Inc.2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON 200370001374690ZAFGEN, INC.175 PORTLAND STREET 4TH FLOOR BOSTON 021140001454189Auspex Pharmaceuticals, Inc.3333 N. TORREY PINES COURT SUITE 400 LA JOLLA 920370001501756Adverum Biotechnologies, Inc.1035 O'BRIEN DRIVE  MENLO PARK 940250001581720Loxo Oncology, Inc.281 TRESSER BOULEVARD, 9TH FLOOR  STAMFORD 069010001588972Recro Pharma, Inc.490 LAPP ROAD  MALVERN 193550001590877REGENXBIO Inc.9600 BLACKWELL ROAD SUITE 210 ROCKVILLE 208500001652923AveXis, Inc.2275 HALF DAY ROAD SUITE 160 BANNOCKBURN 60015




Deerfield International Master Fund, L.P. on the Web
Persons related to Deerfield International Master Fund, L.P. - ANTARES PHARMA, INC.NamePositionCityROBERT F  APPLEPresident & CEO ROBERT F  APPLEEXTONROBERT F  APPLESenior VP and CFO EWINGROBERT F  APPLESenior VP and CFO EWINGROBERT F  APPLEExecutive Vice President & CFO EWINGROBERT F  APPLEExecutive Vice President & COO EWINGDARIO  CARRARAManaging Director-Formulations EXTONDARIO  CARRARASenior Vice President EWINGDARIO  CARRARASenior Vice President EWINGDARIO  CARRARASenior Vice President (1) EWINGLAWRENCE M  CHRISTIANCFO EXTONJAMES L  CLARKDirector EXTONKAUSHIK J  DAVEExecutive Vice President EWINGKAUSHIK J  DAVEExecutive Vice President EWINGDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO /NY  DEERFIELDDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKPHILLIPPE  DRODirector EXTONJOSEPH  EDELMANNEW YORKJames E  FickenscherSenior Vice President & CFO NORRISTOWNJames E  FickenscherSenior Vice President & CFO EWINGJames E  Flynn10% Owner NEW YORKTHOMAS J  GARRITYDirector EXTONTHOMAS J  GARRITYDirector EWINGTHOMAS J  GARRITYDirector EWINGTHOMAS J  GARRITYDirector EWINGTHOMAS J  GARRITYDirector EWINGTHOMAS J  GARRITYDirector EWINGTHOMAS J  GARRITYDirector EWINGJACQUES  GONELLADirector EXTONJACQUES  GONELLADirector EWINGJACQUES  GONELLADirector EWINGJACQUES  GONELLADirector EWINGJACQUES  GONELLADirector EWINGJACQUES  GONELLADirector EWINGPETER J  GRAHAMSVP General Counsel, Secretary LAKE SUCCESSANTON  GUETHDirector EXTONANTON  GUETHDirector EWINGANTON  GUETHDirector EWINGJAMES E  HATTERSLEYEXTONJAMES E  HATTERSLEYVice President-Business Develo EXTONEAMONN P  HOBBSPresident & CEO QUEENSBURYEAMONN P  HOBBSDirector EWINGEAMONN P  HOBBSDirector EWINGEAMONN P  HOBBSPresident and CEO EWINGLEONARD S  JACOBDirector BLUE BELLLEONARD S  JACOBEWINGLEONARD S  JACOBDirector EWINGLEONARD S  JACOBDirector EWINGLEONARD S  JACOBDirector EWINGKeith E  MuckenhirnEWINGPERCEPTIVE ADVISORS LLCWASHINGTONPERCEPTIVE LIFE SCIENCES MASTER FUND LTDWASHINGTONFred M  PowellSenior Vice President & CFO PLYMOUTH MEETINGROBERT P  ROCHE JRDirector ROBERT P  ROCHE JRDirector EWINGPETER L  SADOWSKIVP-Device Group EXTONPETER L  SADOWSKIVice President EWINGPETER L  SADOWSKIVice President EWINGPETER L  SADOWSKISenior Vice President EWINGPETER L  SADOWSKISenior Vice President EWINGPETER L  SADOWSKISenior Vice President EWINGPETER L  SADOWSKIEWINGMARVIN  SAMSONDirector MARVIN  SAMSONDirector EWINGRAJESH C  SHROTRIYADirector EXTONRAJESH C  SHROTRIYADirector EWINGRAJESH C  SHROTRIYADirector EWINGRAJESH C  SHROTRIYADirector EWINGJennifer Evans  StaceySVP, General Counsel & Secty NORRISTOWNJennifer Evans  StaceySVP, General Counsel & Secty EWINGJACK E  STOVERPresident/CEO EXTONJACK E  STOVERPresident/CEO EWINGJACK E  STOVERPresident and CEO EWINGJACK E  STOVERPresident and CEO EWINGPaul K  WottonDirector EXTONPaul K  WottonPresident and CEO EWINGPaul K  WottonPresident and CEO EWINGPaul K  WottonPresident and CEO EWINGPaul K  WottonPresident and CEO EWINGXMARK ASSET MANAGEMENT LLC10% Owner NEW YORKPersons related to Deerfield International Master Fund, L.P. - XENOPORT INCNamePositionCityVincent  AngottiCHIEF EXECUTIVE OFFICER SANTA CLARARonald W  BarrettChief Executive Officer SANTA CLARAGREGORY T  BATESSee Remarks SANTA CLARAPAUL L  BERNSDirector MIDDLETONPAUL L  BERNSDirector SANTA CLARAGianna M  BoskoSVP, CLO and Secretary SANTA CLARAFriedman  CatherineSanta ClaraKenneth C  CundySVP, Preclinical Development SANTA CLARASavello  DavidSanta ClaraDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO /NY  DEERFIELDDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKFenton  DennisSanta ClaraWilliam J  DowerVP, Discovery Biology SANTA CLARAMario  ErnestSanta ClaraDENNIS M  FENTONDirector DENNIS M  FENTONDirector SANTA CLARAFHM III, LLC10% Owner SEATTLEJames E  Flynn10% Owner NEW YORKFrazier Affiliates III, LPSEATTLEFrazier Healthcare III, LPSEATTLEJohn Gordon  FreundDirector PALO ALTOJohn Gordon  FreundDirector PALO ALTOJohn Gordon  FreundDirector PALO ALTOJohn Gordon  FreundDirector PALO ALTOCATHY  FRIEDMANDirector SANTA CLARAMark A  GallopSVP, Research SANTA CLARABosko  GiannaSanta ClaraPAUL  GODDARDDirector SANTA CLARABates  GregorySanta ClaraWilliam G  HarrisSee Remarks SANTA CLARAJERYL L  HILLEMANDirector SANTA CLARAJERYL L  HILLEMANDirector SANTA CLARAHilleman  JerylSanta ClaraFreund  JohnSanta ClaraYASUNORI  KANEKOPALO ALTOPer GH  LofbergDirector SANTA CLARAERNEST  MARIODirector KENNETH J  NUSSBACHERDirector SANTA CLARAROBERT  OVERELLDirector SANTA CLARAROBERT  OVERELLDirector SHORELINEBerns  PaulSanta ClaraKIM  RICHARDSee Remarks SANTA CLARAWILLIAM JL  RIEFLINDirector SO. SAN FRANCISCOWILLIAM JL  RIEFLINPresident SANTA CLARAWILLIAM JL  RIEFLINDirector SANTA CLARABRYAN E  ROBERTSDirector MENLO PARKBRYAN E  ROBERTSDirector SANTA CLARABRYAN E  ROBERTSDirector MENLO PARKBarrett  RonaldSanta ClaraDavid R  SavelloSVP, Development SANTA CLARASkyline Expansion Fund, L.P.PALO ALTOSkyline Expansion Fund Management, LLCPALO ALTOSkyline Venture Management II, LLCPALO ALTOSkyline Venture Management III, LLCPALO ALTOSkyline Venture Partners II, L.P.PALO ALTOSkyline Venture Partners Qualified Purhcaser Fund II, L.P.PALO ALTODavid A  StamlerSVP, Chief Medical Officer SANTA CLARAGARY D  TOLLEFSONDirector SANTA CLARAPierre V  TranSVP and Chief Medical Officer SANTA CLARAASSOCIATES  VENROCK10% Owner NEW YORKVENROCK ASSOCIATES II LP10% Owner NEW YORKVENROCK ENTERPRENEURS FUND LP10% Owner NEW YORKVENROCK MANAGEMENT LLC10% Owner NEW YORKAngotti  VincentSanta ClaraWierenga  WendellSanta ClaraWENDALL  WIERENGADirector SANTA CLARAWENDALL D  WIERENGADirector SAN DIEGOHarris  WilliamSanta ClaraRieflin  WilliamSanta ClaraPersons related to Deerfield International Master Fund, L.P. - AUXILIUM PHARMACEUTICALS INCNamePositionCity14159 capital (GP), LLC10% Owner NEW YORK14159 capital (GP), LLC10% Owner NEW YORK14159 capital (GP), LLC10% Owner NEW YORKADRIAN  ADAMSCEO and President CHESTERBROOKADRIAN  ADAMSCEO and President MALVERNALFRED  ALTOMARIDirector MALVERNARMANDO  ANIDOCEO & President MALVERNEDWARD J  ARCURIEVP, Technical Operations MALVERNJennifer Lou  ArmstrongSenior Vice President, HR MALVERNJennifer Lou  ArmstrongSenior Vice President, HR CHESTERBROOKBaker Biotech Capital (GP), LLC10% Owner NEW YORKBaker Bros. Capital (GP), LLC10% Owner NEW YORKBaker Bros. Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKFELIX  BAKERNEW YORKFELIX  BAKERNEW YORKFELIX  BAKERNEW YORKJULIAN  BAKERNEW YORKJULIAN  BAKERNEW YORKBaker / Tisch Capital (GP), LLCNEW YORKBaker / Tisch Capital (GP), LLC10% Owner NEW YORKEdwin A  Bescherer JrDirector NORRISTOWNEdwin A  Bescherer JrDirector MALVERNPeter C.  BrandtDirector MALVERNPeter C.  BrandtDirector CHESTERBROOKPHILIPPE  CHAMBONDirector NEW YORKPHILIPPE  CHAMBONDirector NEW YORKPHILIPPE  CHAMBONDirector NEW YORKPHILIPPE  CHAMBONDirector NEW YORKPhilippe O.  ChambonDirector NEW YORKPhilippe O.  ChambonDirector NEW YORKWINSTON J  CHURCHILLDirector WAYNEWINSTON J  CHURCHILLDirector WAYNECIP CAPITAL LP10% Owner WAYNEROLF A  CLASSONDirector CHESTERBROOKROLF A  CLASSONDirector TARRYTOWNROLF A  CLASSONDirector MALVERNSUISSE/  CREDIT10% Owner NEW YORK NY 10010SUISSE/  CREDIT10% Owner NEW YORKSUISSE FIRST BOSTON/  CREDITNEW YORKSUISSE FIRST BOSTON/  CREDIT10% Owner NEW YORK,MANAGEMENT CO  DEERFIELDNEW YORKDeerfield Mgmt L.P.NEW YORKDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PARTNERS, LPNEW YORKTITO BENJAMIN J  DEL JREVP, Reg Affairs & Project Mgt MALVERNTITO BENJAMIN J  DEL JREVP, Reg Affairs & Project Mgt CHESTERBROOKAnthony  DelConteChief Medical Officer MALVERNRichard Michael  Dudek JrSenior Vice Pres., Marketing MALVERNOLIVER  FETZERDirector MALVERNOLIVER  FETZERDirector CHESTERBROOKJames E  FickenscherChief Financial Officer NORRISTOWNJames E  FickenscherChief Financial Officer MALVERNJames E  FickenscherChief Financial Officer CHESTERBROOKJames E  FlynnNEW YORKJames E  Flynn10% Owner NEW YORKPAUL A  FRIEDMANDirector MALVERNPAUL A  FRIEDMANDirector CHESTERBROOKRENATO  FUCHSDirector MALVERNMark A  GlickmanEVP - Sales and Marketing MALVERNMark A  GlickmanEVP - Sales and Marketing CHESTERBROOKRoger D  Graham JREVP, Sales & Marketing MALVERNGERALDINE  HENWOODChief Executive Officer NORRISTOWNGERALDINE  HENWOODCEO and Interim President MALVERNJane H  HollingsworthExecutive VP & General Counsel NORRISTOWNELIZABETH VARKI  JOBESChief Compliance Officer MALVERNELIZABETH VARKI  JOBESChief Compliance Officer CHESTERBROOKEdward F  KessigSenior Vice President, Sales MALVERNANDREW I  KOVENEVP, CAO, GC and Secretary MALVERNANDREW I  KOVENEVP, CAO, GC and Secretary CHESTERBROOKDENNIS  LANGERDirector MALVERNCornelius H  Lansing IICFO and Executive VP NORRISTOWNLEHMAN BROTHERS HOLDINGS INCNEW YORKNancy  LurkerDirector MALVERNNancy  LurkerDirector CHESTERBROOKJyrki  MattilaExecutive Vice President NORRISTOWNJyrki  MattilaExecutive Vice President MALVERNWILLIAM  MCKEEDirector MALVERNWILLIAM  MCKEEDirector CHESTERBROOKWILLIAM  MCKEEDirector CHESTERBROOKFRANK H  PEARLWASHINGTONFRANK H  PEARL10% Owner WASHINGTONPERSEUS BIOTECH FUND PARTNERS LLCWASHINGTONPERSEUS BIOTECH FUND PARTNERS LLCWASHINGTONPERSEUS EC LLCWASHINGTONPERSEUS SOROS BIOPHARMACEUTICAL FUND LP10% Owner NEW YORKPERSEUS SOROS BIOPHARMACEUTICAL FUND LP10% Owner NEW YORKPERSEUS SOROS PARTNERS LLCWASHINGTONPERSEUS SOROS PARTNERS LLCNEW YORKPERSEUSPUR LLCWASHINGTONPERSEUSPUR LLCWASHINGTONDennis J  PurcellDirector NEW YORKDennis J  PurcellDirector NORRISTOWNAndrew  SaikCFO CHESTERBROOKSCP PRIVATE EQUITY II LLCWAYNESCP PRIVATE EQUITY PARTNERS II LP10% Owner WAYNETerri B  SebreeSenior Vice President NORRISTOWNSFM AH LLCNEW YORKSFM PARTICIPATION LPNEW YORKSFM PARTICIPATION LPNEW YORKSFM PARTICIPATION LPNEW YORKSOROS FUND MANAGEMENT LLC10% Owner NEW YORKSOROS FUND MANAGEMENT LLC10% Owner NEW YORKGEORGE  SOROSNEW YORKGEORGE  SOROSNEW YORKJennifer Evans  StaceyExecutive VP & General Counsel NORRISTOWNJennifer Evans  StaceyExecutive VP & General Counsel MALVERNJames Patrick  TursiChief Medical Officer MALVERNJames Patrick  TursiChief Medical Officer CHESTERBROOKMICHAEL A  WALLDirector NORRISTOWNROBERT S  WHITEHEADPresident and COO NORRISTOWNALAN  WILLSEVP, Corporate Development MALVERNALAN  WILLSEVP, Corporate Development CHESTERBROOKPersons related to Deerfield International Master Fund, L.P. - NxStage Medical, Inc.NamePositionCityATLAS VENTURE ASSOCIATES III L PWALTHAMATLAS VENTURE ASSOCIATES III L PWALTHAMATLAS VENTURE ASSOCIATES V LPWALTHAMATLAS VENTURE ASSOCIATES V LPWALTHAMATLAS VENTURE ENTREPRENEURS FUND III L PWALTHAMATLAS VENTURE ENTREPRENEURS FUND III L PWALTHAMATLAS VENTURE ENTREPRENEURS FUND V LPWALTHAMATLAS VENTURE ENTREPRENEURS FUND V LPWALTHAMATLAS VENTURE FUND III L P10% Owner WALTHAMATLAS VENTURE FUND III L P10% Owner WALTHAMATLAS VENTURE FUND V LPWALTHAMATLAS VENTURE FUND V LP10% Owner WALTHAMATLAS VENTURE PARALLEL FUND V-A C VWALTHAMATLAS VENTURE PARALLEL FUND V-A C VWALTHAMAgustin  AzelSenior VP, Manufacturing LAWRENCEAugustin  AzelSenior VP, Manufacturing LAWRENCERobert  BrownPresident, NxStage Kidney Care LAWRENCERobert S.  BrownSr. Vice President, CFO LAWRENCERobert S.  BrownPresident, Kidney Care LAWRENCEJeffrey H  BurbankChief Executive Officer LAWRENCEJeffrey H  BurbankCEO LAWRENCEPHILIPPE  CHAMBONDirector NEW YORKPHILIPPE  CHAMBONDirector NEW YORKPHILIPPE  CHAMBONNEW YORK NYPHILIPPE  CHAMBONDirector NEW YORKPHILIPPE  CHAMBONDirector NEW YORK, NYPhilippe O.  ChambonDirector NEW YORKPhilippe O.  ChambonDirector NEW YORKSUISSE/  CREDIT10% Owner NEW YORKSUISSE/  CREDIT10% Owner NEW YORK NY 10010SUISSE/  CREDIT10% Owner NEW YORK, NY 10010SUISSE/  CREDIT10% Owner NEW YORKSUISSE/  CREDITNEW YORK NYSUISSE AG/  CREDIT10% Owner NEW YORKDEERFIELD CAPITAL LPNEW YORKDEERFIELD INTERNATIONAL LTDROAD TOWN, TORTOLADEERFIELD INTERNATIONAL LTDMANAGEMENT CO /NY  DEERFIELDNEW YORKDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PRIVATE DESIGAN FUND L PNEW YORKDEERFIELD PRIVATE DESIGN FUND L PNEW YORKDeerfield Private Design International, L.P.NEW YORKDeerfield Special Situations Fund International LTDROAD TOWN, TORTOLADeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKHeyward R  Donigan VIRGINIA BEACHJames E  Flynn10% Owner NEW YORKJEAN FRANCOIS  FORMELADirector WALTHAMJEAN FRANCOIS  FORMELADirector WALTHAMROBERT G  FUNARI ROBERT G  FUNARIDirector LAWRENCEDaniel A  GianniniDirector LAWRENCEDaniel A  GianniniDirector LAWRENCEDAVID N  GILLSVP & CFO LAWRENCENANCY  HAMDirector BOSTONKevin  HershbergerChief Accounting Officer LAWRENCESAMUEL D  ISALYNEW YORKSAMUEL D  ISALYNEW YORKSAMUEL D  ISALYNEW YORKEARL R  LEWIS EARL R  LEWISDirector LAWRENCEEARL R  LEWIS LAWRENCEEARL R  LEWISDirector LAWRENCEPhilip R  LicariSVP & Chief Operating Officer LAWRENCEMichael  MillerPresident, International LAWRENCEMichael  MillerPresident, International LAWRENCEJean K  MixerDirector LAWRENCECRAIG W  MOORE CRAIG W  MOOREDirector LAKE FORESTCRAIG W  MOOREDirector LAWRENCEORBIMED ADVISORS LLCDirector NEW YORKORBIMED ADVISORS LLCDirector NEW YORKJames J  Peters LAWRENCEPETER P  PHILDIUSDirector LAWRENCEPERPER  REIDDirector LAWRENCEPERPER  REIDDirector LAWRENCEThomas  SheaSVP Manufacturing Operations LAWRENCEThomas  SheaSVP Manufacturing Operations LAWRENCEJay W  ShreinerDirector LAWRENCEJay W  ShreinerDirector LAWRENCEJONATHAN  SILVERSTEINDirector LAWRENCETodd M  SnellSVP, QA, Reg.&Clinical Affairs LAWRENCEBarry M  StraubeDirector LAWRENCEBarry M  StraubeDirector LAWRENCEWinifred L  SwanSVP and General Counsel LAWRENCEWinifred L  SwanSVP and General Counsel LAWRENCEWinifred L  SwanSVP and General Counsel LAWRENCEMATTHEW W  TOWSESVP and Chief Financial Office SOUTH PORTLANDMATTHEW W  TOWSEChief Financial Officer LAWRENCEJoseph E  Turk JrPresident LAWRENCEJoseph E  Turk JrPresident LAWRENCEJoseph E  Turk JrPresident LAWRENCEDavid S  UtterbergDirector LAWRENCEDavid S  UtterbergDirector LAWRENCEMichael J.  WebbSVP, Quality & Regulatory LAWRENCEPersons related to Deerfield International Master Fund, L.P. - eHealth, Inc.NamePositionCitySTEVEN  CAKEBREADSAN FRANCISCOSTEVEN  CAKEBREADDirector SAN FRANCISCOSTEVEN  CAKEBREADDirector SAN FRANCISCOArthur Bruce  CohenNORWALKArthur Bruce  CohenNORWALKArthur Bruce  CohenNORWALKArthur Bruce  CohenNEW YORKSUISSE/  CREDIT10% Owner NEW YORK, NY 10010RAYMOND  DEBBANENEW YORKRAYMOND  DEBBANEBALTIMOREDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO  DEERFIELDNEW YORKMANAGEMENT CO /NY  DEERFIELD10% Owner Deerfield Mgmt L.P.NEW YORKDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKRobert L  FahlmanSr VP, Carrier Relations & COO MOUNTAIN VIEWRobert L  FahlmanSr.VP, Carrier Relations & COO MOUNTAIN VIEWRobert L  FahlmanMOUNTAIN VIEWScott N  FlandersChief Executive Officer CARYScott N  FlandersDirector IRVINEScott N  FlandersDirector MOUNTAIN VIEWJames E  Flynn10% Owner NEW YORKJames E  Flynn10% Owner NEW YORKDavid K.  FrancisChief Financial Officer MOUNTAIN VIEWSamuel C  Gibbs IIISenior Vice President MOUNTAIN VIEWSamuel C  Gibbs IIIPres., eHealth Gov. Systems MOUNTAIN VIEWSamuel C  Gibbs IIISenior Vice President MOUNTAIN VIEWMichael  GoldbergDirector MENLO PARKMichael  GoldbergDirector MENLO PARKMichael  GoldbergDirector MENLO PARKMichael  GoldbergDirector MOUNTAIN VIEWTimothy C.  HannanChief Marketing Officer MOUNTAIN VIEWJoseph Patrick  HealeyNEW YORKJoseph Patrick  HealeyNEW YORKHealthCor Associates, LLCNEW YORKHealthCor Associates, LLCNEW YORKHealthCor Capital, L.P.NEW YORKHealthCor Capital, L.P.NEW YORKHealthCor Group, LLCNEW YORKOHealthCor Group, LLCNEW YORKHealthCor Group, LLCNEW YORKHealthCor Hybrid Offshore GP, LLCNEW YORKHealthCor Hybrid Offshore GP, LLCNEW YORKHEALTHCOR HYBRID OFFSHORE LTDNEW YORKHEALTHCOR HYBRID OFFSHORE LTDNEW YORKHealthCor Hybrid Offshore Master Fund, L.P.NEW YORKHealthCor Hybrid Offshore Master Fund, L.P.NEW YORKHEALTHCOR L PNEW YORKHEALTHCOR L PNEW YORKHEALTHCOR L PNEW YORKHealthCor Long Master GP LLCNEW YORKHealthCor Long Master GP LLCNEW YORKHealthCor Long OffShore Master Fund LPNEW YORKHealthCor Long OffShore Master Fund LPNEW YORKHealthCor Management, L.P.10% Owner NEW YORKHealthCor Management, L.P.10% Owner NEW YORKHealthCor Offshore GP, LLCNEW YORKHealthCor Offshore GP, LLCNEW YORKHealthCor Offshore GP, LLCNEW YORKHEALTHCOR OFFSHORE LTDNEW YORKHEALTHCOR OFFSHORE LTDNEW YORKHealthCor Offshore Master Fund, L.P.NEW YORKHealthCor Offshore Master Fund, L.P.NEW YORKLAWRENCE M  HIGBYDirector NEWPORT BEACHLAWRENCE M  HIGBYDirector MOUNTAIN VIEWThomas R  HitchnerBALTIMOREThomas R  HitchnerBALTIMOREStuart  HuizingaSr. VP & CFO MOUNTAIN VIEWStuart  HuizingaSr. VP & CFO MOUNTAIN VIEWStuart  HuizingaSr. VP & CFO MOUNTAIN VIEWStuart  HuizingaSr. VP & CFO MOUNTAIN VIEWRobert S  HurleyPresident, Medicare Products MOUNTAIN VIEWRobert S  HurleySr. VP, Carrier Relations MOUNTAIN VIEWCV  Invus,NEW YORKCV  Invus,BALTIMOREInvus Group, LLCNEW YORKInvus Group, LLCBALTIMOREJay Walter  JenningsSVP, Finance and APO MOUNTAIN VIEWKLEINER PERKINS CAUFIELD & BYERS IX A LP10% Owner MENLO PARKKLEINER PERKINS CAUFIELD & BYERS IX B LP10% Owner MENLO PARKKPCB IX ASSOCIATES LLC10% Owner MENLO PARKJOSEPH  LACOBDirector MENLO PARKJOSEPH  LACOBDirector MENLO PARKKATHLEEN  LAPORTENEW YORKGary L  LauerChr. of the Board and CEO MOUNTAIN VIEWRANDALL S  LIVINGSTONDirector STANFORDRANDALL S  LIVINGSTONDirector STANFORDRANDALL S  LIVINGSTONDirector WOODSIDEJack L  Oliver IIIDirector CAPE GIRARDEAUJack L  Oliver IIICAPE GURARDEAUJack L  Oliver IIIDirector CAPE GIRARDEAUJack L  Oliver IIIDirector MOUNTAIN VIEWPatel Family Trust U/A/D 12/08/1995ENCINITASSharon Lynn  PatelENCINITASVipool Mohanlal  PatelENCINITASVipool Mohanlal  Patel10% Owner ENCINITASQUESTMARK ADVISERS LLCQUESTMARK ADVISERS LLCBALTIMOREQUESTMARK PARTNERS LP10% Owner QUESTMARK PARTNERS LPBALTIMOREQUESTMARK PARTNERS SIDE FUND LPQUESTMARK PARTNERS SIDE FUND LPBALTIMOREScott  SanbornChief Marketing & Rev. Officer MOUNTAIN VIEWSheryl  SandbergMOUNTAIN VIEWSheryl  SandbergDirector MOUNTAIN VIEWSheryl  SandbergDirector PALO ALTOCHRISTOPHER J  SCHAEPEDirector MENLO PARKBenjamin S  SchapiroBALTIMOREBenjamin S  SchapiroBALTIMOREWilliam T  ShaughnessyPresident and COO MOUNTAIN VIEWEllen O.  TauscherDirector ELYRIAEllen O.  TauscherDirector MOUNTAIN VIEWBruce  TelkampExecutive Vice President MOUNTAIN VIEWBruce  TelkampSr VP, Gen. Counsel & Secrty. MOUNTAIN VIEWBruce  TelkampExecutive Vice President MOUNTAIN VIEWBruce  TelkampExecutive Vice President MOUNTAIN VIEWTom G.  TsaoPresident, Small Business MOUNTAIN VIEWUlys, LLCNEW YORKUlys, LLCBALTIMORESheldon  WangExecutive VP, Technology MOUNTAIN VIEWSheldon  WangSr VP and Chief Tech. Officer MOUNTAIN VIEWSheldon  WangSr. VP and Chief Tech. Officer MOUNTAIN VIEWSheldon  WangExecutive VP, Technology MOUNTAIN VIEWSheldon  WangExec. VP Technology MOUNTAIN VIEWWeiss, Peck & Greer Venture Associates IV Cayman, L.P.MENLO PARKWeiss, Peck & Greer Venture Associates IV, L.L.C.MENLO PARK,WEISS PECK & GREER VENTURE ASSOCIATES V-A LLCMENLO PARKWeiss, Peck & Greer Venture Associates V Cayman, L.P.MENLO PARKWEISS PECK & GREER VENTURE ASSOCIATES V LLCMENLO PARKWPG Enterprise Fund III, L.L.C.MENLO PARK,WPG Information Sciences Entrepreneur Fund II-A, L.L.CMENLO PARKWPG Information Sciences Entrepreneur Fund II, L.L.CMENLO PARKWPG INFORMATION SCIENCES ENTREPRENEUR FUND LPMENLO PARKWPG VC FUND ADVISER II, L.L.C.MENLO PARKWPG VC Fund Adviser, L.L.C.MENLO PARKPersons related to Deerfield International Master Fund, L.P. - Vanda Pharmaceuticals Inc.NamePositionCityALEXANDER E  BARKASPALO ALTOPaolo  BaroldiSVP & Chief Medical Officer ROCKVILLEPaolo  BaroldiSVP & Chief Medical Officer WASHINGTONKENNETH  BATEDirector CAMBRIDGE,Bio One Capital Pte Ltd.SINGAPOREBio One Capital Pte Ltd.CENTROSBiomedical Sciences Investment Fund Pte Ltd.10% Owner SINGAPOREBiomedical Sciences Investment Fund Pte Ltd.10% Owner CENTROSGunther  BirznieksWASHINGTONJAMES C  BLAIR10% Owner PRINCETONCARE CAPITAL  II  LLC10% Owner PRINCETONCARE CAPITAL  II  LLC10% Owner PRINCETONCARE CAPITAL INVESTMENTS II LPPRINCETONCARE CAPITAL INVESTMENTS II LPPRINCETONCare Capital Offshore Investments II LPPRINCETONCare Capital Offshore Investments II LPPRINCETONWilliam D  ClarkROCKVILLEWilliam D  ClarkSr. VP, Chief Business Officer ROCKVILLEMICHAEL F  COLADirector WAYNEMICHAEL F  COLADirector WASHINGTONThomas Lyle  CopmannROCKVILLEDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO  DEERFIELDNEW YORKMANAGEMENT CO /NY  DEERFIELDDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.10% Owner PRINCETONRICHARD W  DUGANDirector GERMANTOWNRICHARD W  DUGANDirector SCOTTSDALERICHARD W  DUGANDirector GIBSONIA, PA 15044EDB Investments Pte Ltd.SINGAPOREEDB Investments Pte Ltd.CENTROSJohn Joseph  FeeneySVP & Chief Medical Officer ROCKVILLEJohn Joseph  FeeneyWASHINGTONJames E  Flynn10% Owner NEW YORKJames E  Flynn10% Owner NEW YORKSteven K  GalsonDirector ROCKVILLESteven K  GalsonDirector WASHINGTONAlbert W.  GianchettiSr.VP,Chief Commercial Officer ROCKVILLEThomas Edward  GibbsSVP, Chief Commercial Officer WASHINGTONRichard L.  GulinoSVP, General Counsel & Sec. WASHINGTONBrian K  HalakDirector PRINCETONRUSSELL C  HIRSCHPALO ALTOWAYNE T  HOCKMEYERDirector GAITHERSBURGStephanie Rast  IrishActing CFO/Treasurer ROCKVILLEHABIB  KAIROUZNEW YORKHABIB  KAIROUZNEW YORKARGERIS N  KARABELASDirector PRINCETONJames Patrick  KellyEVP & Chief Financial Officer ROCKVILLEJames Patrick  KellySVP, CFO, Sec & Treasurer WASHINGTONJAN  LESCHLYPRINCETONJAN  LESCHLYPRINCETONMARK  LESCHLYNEW YORKMARK  LESCHLYNEW YORKMEDIMMUNE INC /DE10% Owner GAITHERSBURGVINCENT  MILANODirector VINCENT  MILANODirector EXTONVINCENT  MILANODirector WASHINGTONROBERT J  MORE10% Owner PRINCETONDeepak Shripad  PhadkeVice President Manufacturing ROCKVILLEHOWARD H  PIENDirector EMERYVILLEHOWARD H  PIENDirector ROCKVILLEMihael Hristos  PolymeropoulosPresident and CEO ROCKVILLEMihael Hristos  PolymeropoulosPresident and CEO WASHINGTONPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLC10% Owner PALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTODavid Russ  RamsayDirector PRINCETONDavid Russ  RamsayDirector PRINCETONRobert  RepellaSVP & Chief Commercial Officer ROCKVILLERobert  RepellaSVP & Chief Commercial Officer WASHINGTONGian Piero  ReverberiSVP & Chief Commercial Officer WASHINGTONRHO CAPITAL PARTNERS INCNEW YORKRHO CAPITAL PARTNERS INCNEW YORKCAPITAL PARTNERS VERWALTUNGS GMBH  RHONEW YORKCAPITAL PARTNERS VERWALTUNGS GMBH  RHONEW YORKRHO MANAGEMENT TRUST INEW YORKRHO MANAGEMENT TRUST INEW YORKRHO MANAGEMENT VENTURES IV LLCNEW YORKRHO MANAGEMENT VENTURES IV LLCNEW YORKRHO VENTURES IV GMBH & CO BETEILIGUNGS KGNEW YORKRHO VENTURES IV GMBH & CO BETEILIGUNGS KGNEW YORKRHO VENTURES IV LP10% Owner NEW YORKRHO VENTURES IV LP10% Owner NEW YORKRHO VENTURES IV QP LPNEW YORKRHO VENTURES IV QP LPNEW YORKJOSHUA  RUCHNEW YORKJOSHUA  RUCHNEW YORKDAVID  SCHNELLPALO ALTOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONSTEVEN A  SHALLCROSSSr. VP, CFO, Treasurer ROCKVILLESTEVEN A  SHALLCROSSSr. VP, CFO, Treasurer ROCKVILLEJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector PALO ALTOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL PARTNERS LPSAN DIEGOKEVIN C  TANG10% Owner SAN DIEGOJESSE I  TREU10% Owner PRINCETONNICOLE  VITULLO10% Owner PRINCETONThomas  WatkinsDirector ROCKVILLEThomas  WatkinsDirector LAKE FORESTPersons related to Deerfield International Master Fund, L.P. - ZAFGEN, INC.NamePositionCityPatricia L  AllenChief Financial Officer CAMBRIDGEPatricia L  AllenCAMBRIDGEGoldberg  AriCambridgeAtlas Venture Associates VII, Inc.CAMBRIDGEAtlas Venture Associates VII, L.P.WALTHAMAtlas Venture Associates VII, L.P.CAMBRIDGEAtlas Venture Fund VII L P10% Owner WALTHAMAtlas Venture Fund VII L P10% Owner CAMBRIDGEGoldberg  AviCambridgeGoldberg  AviCambridgeGoldberg  AviCambridgePeter  BarrettDirector CAMBRIDGEBruce  BoothDirector CAMBRIDGEBooth  BruceCambridgeBooth  BruceCambridgeBooth  BruceCambridgeThomas O  DanielDirector SUMMITDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO /NY  DEERFIELDDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKKim  DennisCambridgeLiam  Ratcliffe  Dr.CambridgeJames E  Flynn10% Owner NEW YORKHeller  FrancesCambridgeAvi Y.  GoldbergDirector BOSTONFrances K  HellerDirector SOUTH SAN FRANCISCOFrances K  HellerDirector BOSTONThomas E.  HughesPresident and CEO CAMBRIDGEStarr  KevinCambridgeStarr  KevinCambridgeStarr  KevinCambridgeStarr  KevinCambridgeDENNIS D  KIMChief Medical Officer LA JOLLADENNIS D  KIMCAMBRIDGEJOHN L  LAMATTINADirector NEW YORKJOHN L  LAMATTINACAMBRIDGEJOHN L  LAMATTINADirector STONINGTONMARK J  LEVINCAMBRIDGEMARK J  LEVINBOSTONTartaglia  LouCambrdigeTartaglia  LouCambridgeTartaglia  LouisCambridgeTartaglia  LouisCambridgePatrick  LoustauPresident CAMBRIDGEJaffe  MatthiasCambridgeJaffe  MatthiasCambridgeJaffe  MatthiasCambridgeCameron Geoffrey  McDonoughDirector SOUTH PLAINFIELDBloom  MitchellBostonBloom  MitchellBostonBloom  MitchellBostonBloom  MitchellBostonROBERT J  PEREZDirector LEXINGTONBarrett  PeterCambridgeBarrett  PeterCambridgeBarrett  PeterCambridgeAlicia  SecorChief Commercial Officer LEXINGTONAlicia  SecorChief Commercial Officer CAMBRIDGEKEVIN P  STARRDirector CAMBRIDGEKEVIN P  STARRDirector BOSTONROBERT I  TEPPERCAMBRIDGEROBERT I  TEPPERBOSTONThird Rock Ventures GP, L.P.BOSTONThird Rock Ventures GP, L.P.BOSTONTHIRD ROCK VENTURES LP10% Owner BOSTONTHIRD ROCK VENTURES LP10% Owner BOSTONFRANK E  THOMASDirector ANN ARBORFRANK E  THOMASCAMBRIDGEHughes  ThomasCambridgeHughes  ThomasCambridgeHughes  ThomasCambridgeTRV GP, LLCBOSTONTRV GP, LLCBOSTONPersons related to Deerfield International Master Fund, L.P. - Auspex Pharmaceuticals, Inc.NamePositionCitySommer  AndreasVistaSommer  AndreasLa JollaSommer  AndreasLa JollaSommers  AndreasVistaLynn Dorsey  BleilDirector SAN DIEGOBHARAT M  CHOWRIRAChief Operating Officer BOULDERBHARAT M  CHOWRIRAChief Operating Officer SAN DIEGOBHARAT M  CHOWRIRAChief Operating Officer SAN DIEGOCMEA Ventures VII LP10% Owner SAN FRANCISCOCMEA VENTURES VII (PARALLEL) LPSAN FRANCISCOStamler  DavidLa JollaStamler  David.La JollaCollier  DavidSan FranciscoCollier  DavidSan FranciscoCollier  DavidSan FranciscoDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO  DEERFIELDNEW YORKMANAGEMENT CO /NY  DEERFIELDDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Private Design Fund II, L.P.NEW YORKDeerfield Private Design International II, L.P.ROAD TOWN, TORTOLADeerfield Private Design International II, L.P.NEW YORKDeerfield Private Design International II, Ltd.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKRODNEY A  FERGUSONDirector RODNEY A  FERGUSONDirector CAMPBELLRODNEY A  FERGUSONSAN DIEGOJames E  Flynn10% Owner NEW YORKAggarwal  GauravLa JollaR SCOTT  GREERDirector R SCOTT  GREERDirector SAN DIEGOR SCOTT  GREERDirector SAN DIEGOFritz  LawrenceLa JollaFritz  LawrenceLa JollaGrey  MichaelVistaPanorama Capital, L.P.10% Owner CAMPBELLShah  PratikSan FranciscoShah  PratikLa JollaShah  PratikVistaShah  PratikLa JollaGERALD T  PROEHLDirector SAN DIEGOGERALD T  PROEHLDirector SAN DIEGOGERALD T  PROEHLDirector SAN DIEGOGilmore  R.VistaFerguson  RodLa JollaNewbold  RonVistaSamuel R  SaksChief Development Officer PALO ALTOSamuel R  SaksChief Development Officer SAN DIEGOSamuel R  SaksChief Development Officer SAN DIEGOSachs  SamVistaSaks  SamuelVistaSaks  SamuelLa JollaSaks  SamuelLa JollaSepehr  SarsharDirector SAN DIEGOJohn P.  SchmidChief Financial Officer SAN DIEGOJohn P.  SchmidSAN DIEGOJohn P.  SchmidChief Financial Officer SAN DIEGOPHILLIP M  SCHNEIDERDirector CARLSBADPHILLIP M  SCHNEIDERDirector SAN DIEGOSarshar  SepVistaSarshar  SepLa JollaSharshar  SepLa JollaSarshar  SepehrVistaSarshar  SepehrLa JollaPratik  ShahPresident and CEO MINNEAPOLISPratik  ShahPresident and CEO SAN DIEGOPratik  ShahPresident and CEO SAN DIEGOANDREAS  SOMMERSAN DIEGODavid A  StamlerChief Medical Officer SANTA CLARADavid A  StamlerSAN DIEGODavid A  StamlerChief Medical Officer LA JOLLAGant  ThomasVistaThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II L.P.10% Owner MINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II, LLCDirector MINNEAPOLISThomas, McNerney & Partners II, LLCDirector MINNEAPOLISThomas, McNerney & Partners II, LLCDirector MINNEAPOLISTMP Associates II LPMINNEAPOLISTMP Associates II LPMINNEAPOLISTMP Associates II LPMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISAlex  ZissonDirector MINNEAPOLISAlex  ZissonDirector SAN DIEGOAlex  ZissonDirector MINNEAPOLISAlex  ZissonDirector MINNEAPOLISPersons related to Deerfield International Master Fund, L.P. - Adverum Biotechnologies, Inc.NamePositionCityLinda  BainChief Financial Officer CAMBRIDGELinda  BainMENLO PARKSamuel B.  BaroneSVP, Clinical Development MENLO PARKMark S.  BlumenkranzDirector MENLO PARKShirley  BraunVP, Human Resources MENLO PARKThomas W.  ChalbergChief Executive Officer MENLO PARKJennifer C.  ChengMENLO PARKPaul B  ClevelandChief Executive Officer PALO ALTOAthena  CountouriotisSVP, Chief Medical Officer SAN DIEGOMANAGEMENT CO  DEERFIELDNEW YORKDeerfield Mgmt III, L.P.NEW YORKDeerfield Mgmt L.P.NEW YORKDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Private Design Fund III, L.P.NEW YORKDeerfield Private Design Fund III, L.P.ROAD TOWN, TORTOLADeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKMitchell H.  FinerDirector CAMBRIDGEJames E  Flynn10% Owner NEW YORKJames E  FlynnNEW YORKMehdi  GasmiChief Science & Tech Officer MENLO PARKJOHN PATRICK ET AL  GUERINDirector LOS ANGELESHull  HansMenlo ParkAnders D  HovePALO ALTOHans  HullChief Executive Officer MENLO PARKMcLaughlin  JohnMenlo ParkMcLaughlin  JohnMenlo ParkBong Y  KohPALO ALTOBain  LindaMenlo ParkClarence Patrick  MachadoDirector SAN FRANCISCOBlumenkranz  MarkMenlo ParkBlumenkranz  MarkSan FranciscoBlumenkranz  MarkMenlo ParkJOHN PETER  MCLAUGHLINDirector SOUTH SAN FRANCISCOJOHN PETER  MCLAUGHLINDirector MENLO PARKJOHN PETER  MCLAUGHLINDirector MENLO PARKGasmi  MehdiMenlo ParkLEONE D  PATTERSONCFO EMERYVILLEWachter  PaulMenlo ParkWachter  PaulMenlo ParkREGENERON PHARMACEUTICALS INC10% Owner TARRYTOWNBRYAN E  ROBERTSPALO ALTORoman G.  RubioSVP, Translational Medicine MENLO PARKCarlo  RussoEVP and Chief Medical Officer MENLO PARKAmber  SalzmanPresident and CEO MENLO PARKSteven Daniel  SchwartzDirector MENLO PARKRichard N.  SpiveyDirector LEXINGTONSchwartz  StevenMenlo ParkSchwarz  StevenSan FranciscoSchwartz  StevenMenlo ParkMichael  SwartzburgPrincipal Accounting Officer MENLO PARKChalberg  ThomasMenlo ParkChalberg  ThomasSan FranciscoChalberg  ThomasMenlo ParkVenrock Associates VI, L.P.10% Owner PALO ALTOVenrock Healthcare Capital Partners II, L.P.10% Owner PALO ALTOVENROCK HEALTHCARE CAPITAL PARTNERS LPPALO ALTOVenrock Management VI, LLCPALO ALTOVenrock Partners Management VI, LLCPALO ALTOVenrock Partners VI, L.P.PALO ALTOCapital (Switzerland) GmbH  Versant IVBASELLuxco S.a r.l.  Versant IVLUXEMBOURGVersant Venture Capital IV, L.P.MENLO PARKVersant Ventures IV, LLCMENLO PARKVHCP Co-Investment Holdings II, LLCPALO ALTOVHCP Co-Investment Holdings, LLCPALO ALTOVHCP Management II, LLCPALO ALTOVHCP Management, LLCPALO ALTOPaul  WachterDirector NEW YORKPaul  WachterDirector MENLO PARKThomas  WoiwodeDirector MENLO PARKZygtech, LLC10% Owner SHORT HILLSPersons related to Deerfield International Master Fund, L.P. - Loxo Oncology, Inc.NamePositionCityACCESS INDUSTRIES MANAGEMENT, LLCNEW YORKAI Loxo Holdings LLC10% Owner NEW YORKAI Value Holdings, LLCNEW YORKAISLING CAPITAL III LP10% Owner NEW YORKAISLING CAPITAL III LP10% Owner NEW YORKAisling Capital Partners III LLCNEW YORKAisling Capital Partners III LLCNEW YORKAisling Capital Partners III LPNEW YORKAisling Capital Partners III LPNEW YORKARRAY BIOPHARMA INC10% Owner BOULDERNaider  AviStamfordM JAMES  BARRETTDirector BALTIMOREM JAMES  BARRETTDirector TIMONIUMPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner TIMONIUMJoshua H.  BilenkerPresident & CEO WARRENLen  BlavatnikNEW YORKDavid P  BonitaDirector SAN DIEGODavid P  BonitaDirector STAMFORDJennifer  BursteinVice President of Finance STAMFORDBonita  DavidStamfordMANAGEMENT CO  DEERFIELDNEW YORKDeerfield Mgmt L.P.NEW YORKDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKGoldstein  DovNew YotkGoldstein  DovStamfordRYAN D  DRANT10% Owner TIMONIUMSTEVE  ELMSDirector CHESTERSTEVE  ELMSDirector NEW YORKKeith T.  FlahertyDirector BOULDERKeith T.  FlahertyDirector STAMFORDAnthony A. Jr.  Florence10% Owner CHEVY CHASEJames E  Flynn10% Owner NEW YORKJames E  FlynnNEW YORKAlan  FuhrmanDirector BOTHELLAlan  FuhrmanDirector STAMFORDDOV A MD  GOLDSTEINCFO and Treasurer KING OF PRUSSIADOV A MD  GOLDSTEINCFO and Treasurer STAMFORDSteve  HarrDirector SEATTLESAMUEL D  ISALYSAMUEL D  ISALYNEW YORKBarrett  JamesStamfordBilenker  JoshuaNew YorkBilenker  JoshuaStamfordFlaherty  KeithStamfordPATRICK J  KERINS10% Owner TIMONIUMKRISHNA KITTU  KOLLURI10% Owner TIMONIUMLori Anne  KunkelDirector SUNNYVALELori Anne  KunkelSTAMFORDJennifer A.  LowChief Medical Officer STAMFORDTIMOTHY M  MAYLEBENDirector ANN ARBORDAVID M  MOTT10% Owner TIMONIUMMikel Paul  MoyerSTAMFORDAvi Z.  NaiderDirector STAMFORDNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.10% Owner TIMONIUMORBIMED ADVISORS LLCDirector ORBIMED ADVISORS LLC10% Owner NEW YORKOrbiMed Capital GP V LLCNEW YORKDennis J  PurcellNEW YORKDennis J  PurcellNEW YORKSCOTT D  SANDELL10% Owner TIMONIUMANDREW N  SCHIFFNEW YORKDR DREW  SCHIFFNEW YORKPeter W.  Sonsini10% Owner MENLO PARKElms  StevenNew YorkElms  StevenStamfordNaarden Jacob  VanChief Business Officer STAMFORDRavi  Viswanathan10% Owner TIMONIUMHarry R  Weller10% Owner TIMONIUMPersons related to Deerfield International Master Fund, L.P. - Recro Pharma, Inc.NamePositionCityLudomirski  AbrahamMalvernAltomari  AlfredMalvernALFRED  ALTOMARIDirector PRINCETONALFRED  ALTOMARIDirector MALVERNWilliam  AshtonDirector BETHESDAWilliam  AshtonDirector MALVERNMichael  BerelowitzDirector NEW YORKMichael  BerelowitzDirector MALVERNBroadfin Capital, LLCNEW YORKBroadfin Capital, LLCNEW YORKBroadfin Capital, LLCNEW YORKBroadfin Healthcare Master Fund Ltd10% Owner GRAND CAYMANBroadfin Healthcare Master Fund Ltd10% Owner GRAND CAYMANMichael  CelanoChief Financial Officer BETHLEHEMGarner  CharlesMalvernWINSTON J  CHURCHILLDirector EXTONWINSTON J  CHURCHILLDirector MALVERNDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO /NY  DEERFIELDDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKNichols  DonnaMalvernJames E  Flynn10% Owner NEW YORKKaren  FlynnDirector LIONVILLECharles  GarnerCFO and Chief Business Officer MALVERNHenwood  GerriMalvernFred  GraffChief Commercial Officer MALVERN,GERALDINE  HENWOODChief Executive Officer CAMBRIDGEGERALDINE  HENWOODPresident and CEO MALVERNKEVIN  KOTLERNEW YORKKEVIN  KOTLERNEW YORKRyan David  LakeSenior VP, Finance & CAO EXTONABRAHAM  LUDOMIRSKIDirector MALVERNABRAHAM  LUDOMIRSKIDirector MALVERNRandall  MackSenior VP, Development MALVERNStewart  McCallumChief Medical Officer MALVERN,Berelowitz  MichaelMalvernDiane  MyersSenior VP-Reg/Quality MALVERNDonna  NicholsCAO/Controller MALVERNBryan M.  ReasonsDirector HAYWARDSCP Vitalife Partners II LP10% Owner MALVERNSCP Vitalife Partners (Israel) II, L.P.10% Owner MALVERNStonepine Capital Management, LLC10% Owner BENDWeisman  WayneMalvernWayne  WeismanDirector MALVERNAshton  WilliamMalvernChurchill  WinstonMalvernPersons related to Deerfield International Master Fund, L.P. - REGENXBIO Inc.NamePositionCityDaniel  Abdun-NabiDirector GAITHERSBURGFaraz  AliChief Business Officer ROCKVILLEFox  AllanWashingtonFox  AllanWashingtonFox  AllanRockvilleAuspitz  BenjaminWashingtonAuspitz  BenjaminRockvilleLUKE M  BESHARDirector EAST RUTHERFORDSamuels  CamilleRockvillePatrick J.  ChristmasSVP, General Counsel BRIDGETONKiser  DanielWashingtonOlivier  DanosChief Scientific Officer ROCKVILLEDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO /NY  DEERFIELDDeerfield Mgmt III, L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Private Design Fund III, L.P.NEW YORKHayden  DonWashingtonHayden, Jr.  DonaldWashingtonHayden, Jr.  DonaldRockvilleEDGAR  ENGLEMANDirector REDWOOD CITYJames E  Flynn10% Owner NEW YORKFMR CORP10% Owner BOSTONAllan M.  FoxDirector ROCKVILLEDONALD J  HAYDEN JRDirector PRINCETONKiser  JohnWashingtonARGERIS N  KARABELASDirector SAN DIEGOMills  KennethWashingtonMills  KennethWashingtonMills  KennethRockvilleBeshar  LukeRockvilleKenneth T.  MillsPresident and CEO ROCKVILLECamille D  SamuelsDirector MENLO PARKCurran  SimpsonSVP, Technical Operations ROCKVILLEDAVID C  STUMPDirector ROCKVILLEDaniel  TasseDirector HAMPTONVittal  VasistaChief Financial Officer ROCKVILLEStephen  YooChief Medical Officer ROCKVILLEPersons related to Deerfield International Master Fund, L.P. - AveXis, Inc.NamePositionCityKnudten  AndrewBannockburnKoh  BongBannockburnKaspar  BrianBannockburnNuechterlain  CaroleBannockburnThomas J.  DeeSr. VP & CFO BANNOCKBURNDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO /NY  DEERFIELDDeerfield Mgmt III, L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Private Design Fund III, L.P.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKJames E  FlynnDirector NEW YORKL'Italien  JamesBannockburnMichael  JohannesenGeneral Counsel BANNOCKBURNHarkey  JohnBannockburnLeff  JonathanBannockburnBrian K.  KasparChief Scientific Officer BANNOCKBURNTerrence C  KearneyDirector LAKE FORESTAndrew F.  KnudtenSrVP/Manufacture&Supply Chain BANNOCKBURNBong Y  KohDirector PALO ALTOJONATHAN S  LEFFDirector BRISBANEJAMES J  LITALIENSrVP/Chief Reg&Quality Officer SAN DIEGOPaul B  ManningDirector ALLEGANRick  ModiChief Business Officer CAMBRIDGESukumar  NagendranSr. VP & Chief Medical Officer BANNOCKBURNSean P.  NolanPresident & CEO BRISBANECarole  NuechterleinDirector BANNOCKBURNManning  PaulBannockburnPBM Capital Investments, LLCBANNOCKBURNNolan  SeanBannockburnR.A.  Session IISr. VP, Corp Strategy BANOCKBURNJoao MD  SiffertDirector ALISO VIEJOLori J.  SmithSVP-Chief Human Resource Off. BANNOCKBURNNagendran  SukumarBannockburnDee  ThomasBannockburnFrank  VerwielDirector BRISBANEDANIEL G  WELCHDirector BRISBANE
Potentially same personNameCityCountryDeerfield International Master Fund, L.P.NEW YORKNY












 






